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Clinical Decision-Making in Aphasia Therapy:
A Survey of Percieved Levels of Evidence for Common Treatment Approaches
Erin T. Rowe, B.S.
ABSTRACT
The past three decades have produced a surge of interest in the role of evidencebased practice (EBP) in the clinical decision-making of speech-language pathologists and
other healthcare professionals in delivering optimally effective patient care. A review of
the literature revealed several studies investigating potential barriers to EBP
implementation and attitudes toward EBP. However, few studies have been designed to
probe what treatment approaches to neurogenic communication disorders clinicians are
currently implementing and the rationales behind their use. Furthermore, a review of the
literature failed to reveal any surveys designed to probe the correlation between what
clinicians perceive to be evidence based and what truly is evidence based as outlined in
current practice guidelines. The primary aim of this study was to examine potential
trends within the field of speech-language pathology relating to the role of EBP in the
clinical decision-making of aphasia therapy and the quality of evidentiary support for
these decisions. Launching both Web-based and hard copy versions of an 18-question
survey, questions probed clinicians’ perceptions of the evidence level, primary sources of
information, and timeframe of implementation related to various traditional treatment
x

approaches for aphasia. Analysis of the 104 survey responses revealed a disconnect
between the implementation of aphasia treatments and the research behind their use.
Results indicate that many of the common treatment approaches for aphasia currently in
practice are evidence based. However, a research-to-practice gap exists as many
treatment approaches that clinicians are not reportedly using are also supported by
evidence. Similarly, clinicians’ perceptions of what is evidence based are not always in
accordance with current practice guidelines. Clinicians appear to rely on professional
journals, graduate school training, and professional conferences as their primary sources
of evidence-based information. It does not appear as though advertising significantly
affects clinicians’ decision making in treatment selection. Furthermore, clinicians tend to
implement new or alternative treatment approaches rather quickly after exposure to the
treatment. Although participants reportedly acknowledge the importance of EBP, further
research is needed to investigate causes of and ways to eliminate the research-to-practice
gap in the treatment of neurological communication disorders.
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CHAPTER ONE:
INTRODUCTION
Evolution of Evidence-Based Practice
The evidence-based practice (EBP) paradigm, originating in the field of medicine
as evidence-based medicine (EBM), is now used in a variety of disciples and
rehabilitation fields. Although scientific research had previously been used to guide
clinical decision making prior to healthcare professionals recognizing the importance of
an explicit EBP model, interest in EBP has increased significantly in the past three
decades (Zipoli & Kennedy, 2005). EBP can now be found within the literature in the
fields of medicine (e.g., McAlister, Graham, Karr, Laupacis, 1999), speech-language
pathology (e.g., Dollaghan, 2004), physical therapy (e.g., Connolly, Lupinacci, & Bush,
2001), occupational therapy (e.g., Dubouloz, Egan, Vallerand, & von Zweck, 1999),
psychology (e.g., Meehl, 1997), and nursing (e.g., Brady & Lewin, 2007).
In perhaps the most commonly used definition, Sackett, Rosenberg, Gray, Haynes,
and Richardson (1996) describe EBP as “the conscientious, explicit and judicious use of
current best evidence in making decisions about the care of individual patients… [by]
integrating individual clinical expertise with the best available external clinical evidence”
(p. 71). In 2000, the definition was revised to include consideration of patient perspective
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and preferences regarding their healthcare decisions (Sackett, Straus, Richardson,
Rosenberg, & Haynes).
According to the American Speech-Language-Hearing Association (2008), the
EBP procedure entails four steps: 1) framing the clinical question, 2) finding the
evidence, 3) assessing the evidence, and 4) making the clinical decision. At the crux of
EBP is a three-fold clinical decision-making model in which decisions should include
consideration of three sources: 1) evidence from systematic research, 2) the clinician’s
clinical expertise and experiences, and 3) the values and preferences of the individual(s)
being served (Brackenbury, Burroughs, Hewitt, 2008). A graphic illustration of the EBP
clinical decision-making paradigm can be found in Figure 1.

Figure 1. Components of Clinical Decision-Making for Evidence-Based Practice
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Benefits of EBP
In addition to the primary benefit of aiding speech-language pathologists and other
healthcare professionals in delivering optimally effective patient care, additional
advantages of EBP include reduction in the variation of service provisions, assisting in
lobbying for speech-language pathology and audiology services within legislation,
allowing clinicians to keep updated on clinical literature, and assisting to bridge the
research-to-practice gap. EBP also allows clinicians to become lifelong learners and
continuously improve their clinical expertise (Peach, 2002).
It is also important to recognize EBP’s advantage of increased accountability, not
only to clients and their families but to students in training and to third-party payers
(Brackenbury et al., 2008). According to a study by Vallino-Napoli and Reilly (2004),
adherence to EBP principles can ease clinicians’ “constant position to support their
diagnostic and therapeutic recommendations, justify service obtainment and continuation,
and seek health care funding and reimbursements” (p. 107).

Levels of Evidence
It would be imprudent and risky, however, to assume that all evidence is of equal
quality. According to Robey (2004), “the terms ‘levels of evidence’ or ‘strength of
evidence’ refer to systems for classifying the evidence in a body of literature through a
hierarchy of scientific rigor and quality” (p. 5). Reviewers must select the most relevant
levels-of-evidence system for the type of procedure they are assessing (e.g., diagnosis,
prognosis, safety, efficacy, and effectiveness) (Robey, 2004). With the field of
3

communication sciences and disorders (CSD) promoting the utilization of EBP
principles, the American Speech-Language-Hearing Association (ASHA) has developed
guidelines for levels of evidence in studies of treatment efficacy (2010). These guidelines
allow clinicians to assess the methodological quality and scientific rigor of a study which
may influence their clinical practices. The ASHA recommended levels of evidence can be
found in Table 1.

Table 1. ASHA’s Recommended Hierarchy of Evidence (Adapted from ASHA, 2010)
Level

Description

Ia.

Well-designed meta-analysis of > 1 randomized control trial

Ib.

Well-designed randomized control study

IIa.

Well-designed control study without randomization

IIb.

Well-designed quasi-experimental study

III

Well-designed non-experimental study (i.e., correlation and case
studies)

IV

Expert committee report, consensus conference, clinical experience

The research designs of studies vary in their ability to predict the outcomes of a
particular clinical question. Many researchers have developed hierarchies of evidence or
evidence pyramids to depict the gradations in evidence. For example, the U.S. Preventive
Services Task Force created a five-tiered hierarchy of evidence including 1) randomized
controlled trials (RCT), 2) nonrandomized control trials, 3) cohort or case-control studies,
4) multiple time series, and 5) expert opinions, descriptive studies, and case reports.
Similarly, the Oxford Centre for Evidence Based Medicine (CEBM) created an approach
4

for systematizing the process of determining evidence based on research question type.
The Oxford CEBM’s levels of evidence can be found in Table 2.

Table 2. The Oxford Centre for Evidence Based Medicine Levels of Evidence (Adapted
from Phillips et al., 1998)
Level

Description

1a.

Systematic review (with homogeneity) of randomized-controlled
trials (RCT)

1b.

Individual RCT (with narrow confidence interval)

2a.

SR (with homogeneity) of cohort studies

2b.

Individual cohort study (including low quality RCT)

2c.

“Outcomes” research; Ecological studies

3a.

SR (with homogeneity) of case control studies

3b.

Individual case-control studies

4

Case series and poor quality cohort and case-control studies

5

Expert opinion without explicit critical appraisal, or based on
physiology, bench research, or “first principles”

ASHA’s Response to EBP
Because EBP affects all aspects of patient care, it compromises the ASHA Scope
of Practice at all levels of clinical decision-making (ASHA, 2004). The American
Speech-Language-Hearing Association (ASHA) recognizes EBP as a continuous process
with dynamic integration of clinical expertise and external evidence. According to
Principle I of ASHA’s Code of Ethics (2003), clinicians “shall evaluate the effectiveness
of services rendered and of products dispensed and shall provide services or dispense
products only when benefit can reasonably be expected” (p. 2). With an underlying
5

theme of EBP included in each principle, the Code holds the welfare of patients
paramount. The Principles of the ASHA Code of Ethics can be found in Table 3.

Table 3. Principles of the ASHA Code of Ethics (2003)
Principle I

“Individuals shall honor their responsibility to hold
paramount the welfare of persons they serve professionally or
participants in research and scholarly activities and shall treat
animals involved in research in a humane manner.”

Principle II

“Individuals shall honor their responsibility to achieve and
maintain the highest level of professional competence.”

Principle III

“Individuals shall honor their responsibility to the public by
promoting public understanding of the professions, by
supporting the development of services designed to fulfill the
unmet needs of the public, and by providing accurate
information in all communications involving any aspect of the
professions, including dissemination of research findings and
scholarly activities.”

Principle IV

“Individuals shall honor their responsibilities to the
professions and their relationships with colleagues, students,
and members of allied professions. Individuals shall uphold
the dignity and autonomy of the professions, maintain
harmonious interprofessional and intraprofessional
relationships, and accept the professions' self-imposed
standards.”

ASHA also recognizes its critical role in promoting the use of EBP for speechlanguage pathologists and audiologists. In 1993, ASHA formed a Task Force on
Treatment Outcomes and Cost Effectiveness in order to provide its members with
outcomes data for various speech-language pathology and audiology services. After
reviewing national databases and data collection systems, the Task Force began
development of a national database for the field of CSD, and in 1997 the National
6

Outcomes Measurement System (NOMS) was developed. Designed to collect aggregated
national outcomes data, NOMS is a data collection system used to illustrate the value of
speech-language pathology and audiology services for individuals with communication
and/or swallowing disorders.
NOMS is based on ASHA’s Functional Communication Measures (FCMs), a
series of disorder-specific, seven-point rating scales designed to describe the change(s) in
functional communication and/or swallowing ability over time. FCMs are determined at
the time of a patient’s admission and again at discharge to depict the amount of change in
communication and/or swallowing as a result of speech and language intervention.
Therefore, FCMs allow clinicians to demonstrate the benefit(s) of treatment to not only
the patient but to policy makers, third party payers, and administrators.
In 2004, Celia Hooper, vice president for professional practices in speechlanguage pathology, and Ray Kent, vice president for research and technology, formed
ASHA’s Joint Coordinating Committee on Evidence-Based Practice. According to the
Report of the Joint Coordinating Committee on Evidence-Based Practice (2004), the chief
responsibility of the committee is “assessing the issues of evidence-based practice relative
to planning needs and development opportunities” for ASHA (p. 1).
In 2005, ASHA’s Executive Board established the Advisory Committee on
Evidence-Based Practice as a standing committee of the Association. The committee’s
charge is to: 1) establish a set of terminology and definitions related to evidence-based
practice for consistent use throughout ASHA, 2) identify and prioritize clinical questions,
3) convene panels of independent knowledgeable reviewers to conduct evidence
7

review on clinical questions, 4) establish processes for the conduct and dissemination of
evidence reviews, and 5) advise National Office staff on members' needs in the area of
evidence-based practice.
Currently, ASHA provides numerous web-based tutorials relating to different
aspects of EBP including how to frame the clinical question, how to find the evidence,
and how to critically make clinical decisions. ASHA has also compiled an EvidenceBased Practice Glossary. Adapted from definitions from various sources including the
Oxford Centre for Evidence-Based Medicine (CEBM), the Scottish International
Guidelines Network (SIGN), and the University of Toronto Centre for Evidence-Based
Medicine, ASHA’s EBP glossary provides a resource for clinicians to improve their
understanding of EBP concepts.
ASHA’s National Center for Evidence-Based Practice in Communication
Disorders (N-CEP) now provides ASHA members with an EBP Compendium, allowing
access to practice guidelines and systematic reviews to be used as tools for clinical
decision making. According to ASHA, systematic reviews are “formal assessments of the
body of scientific evidence related to a clinical question, and describe the extent to which
various diagnostic or treatment approaches are supported by the evidence, but stop short
of making specific recommendations for clinical practice” (www.asha.org, 2009). ASHA
promotes the use of systematic reviews as a time-saving resource for clinicians wishing to
incorporate EBP into their clinical practices. According to ASHA’s 2004 Report of the
Joint Coordinating Committee on Evidence-Based Practice, clinical practice guidelines
(CPG) “meet rigorous criteria and are based on a systematic review of existing scientific
8

evidence published in peer-reviewed journals” (p. 8). Practice guidelines serve as the
official statement of ASHA and provide guidance for incorporating evidence-based best
practices into clinical decision making. Furthermore, the Academy of Neurologic
Communication Disorders and Sciences (ANCDS) provides clinicians with practice
guidelines for the management of communication disorders in neurologically impaired
individuals.
ASHA’s endorsement of EBP is not only directed toward practicing clinicians but
also toward graduate student clinicians in training. Revising previous certification
standards, the 2005 Standards and Implementation Procedures for the Certificate of
Clinical Competence (CCC) in Speech-Language Pathology went into effect for all SLP
applicants whose applications were received beginning January 1, 2006. As part of the
revision, the Council for Clinical Certification (CFCC) initiated use of the Knowledge
and Skills Acquisition (KASA) Summary Form for certification in speech-language
pathology and audiology. The KASA form tracks graduate students’ progress in gaining
the knowledge and skills delineated in the Standards for Certificate of Clinical
Competence (SCCC). Through the use of this document, the SCCC encourages graduate
programs to utilize the KASA form as a tracking document to demonstrate compliance
with accreditation standards to meet ASHA certification requirements.
The KASA form consists of seven standards. While use of best clinical practices
is an underlying theme throughout the KASA form, Standard III-F explicitly addresses
the use of EBP. According to Standard III-F, “The applicant must demonstrate
knowledge of the processes used in research and the integration of research principles
9

into evidence-based clinical practice” (ASHA, 2005). To implement this standard, the
applicant must 1) demonstrate comprehension of the principles of basic and applied
research and research design, 2) demonstrate understanding of how to access sources of
research information, and 3) have experience relating research to clinical practice
(ASHA, 2005). Graduate school program documentation in fulfillment of this standard
may include information obtained via clinical experiences, research projects, independent
studies, and class projects.
As a means of demonstrating compliance with accreditation standards to meet
ASHA certification requirements, a majority of graduate programs nationwide are now
utilizing the KASA form. Therefore, since 2006, these programs now increasingly
emphasize the role of EBP and require students to demonstrate application of research to
clinical practice in fulfillment of KASA Standard III-F.

The Research-to-Practice Gap
Despite the endorsement of EBP principles by ASHA, the feasibility of
implementing such a model into everyday clinical practices remains an area of concern.
In a 2005 survey study of 240 speech-language pathologists, Zipoli and Kennedy reported
that although the respondents reported generally positive attitudes toward EBP and
research, respondents reported using more traditional sources of information (i.e., clinical
experience and opinions of colleagues) than evidence-based sources. In accordance with
Fey’s (2006) concerns regarding the amount of time required for EBP, the most
frequently reported perceived barrier to EBP in Zipoli and Kennedy’s study was lack of
10

professional time. Additional barriers dissuading clinicians from implementing EBP into
clinical decision making include limited understanding of the components of the model
and limited frequency with which available sources of evidence are accessed (VallinoNapoli & Reilly, 2004). Furthermore, Brackenbury et al. (2008) cautions clinicians that
research relating to a particular clinical question may be “limited, contradictory, or
nonexistent” (p. 87).
An area that perhaps requires further study is the potential inverse relationship
between clinical experience and implementation of EBP. In a 2004 survey study of
speech pathologists in Victoria, Australia, Vallino-Napoli and Reilly report that clinicians
who had been practicing for more than 10 years were less likely to use research findings
to guide clinical decision making. Possible causes for this reduction in EBP include
changes in training curriculum and increased reliance on clinical judgment based on
experience.
The research-to-clinical practice gap must be acknowledged before suggestions
can be made in bridging the divide. Greenhalgh (1998) explained “There is a huge
difference between efficacy (how well something works in the laboratory or controlled
environment of the clinical research trial) and effectiveness (how well it works in the
‘real world’)” (p. 3). Similarly, Nail-Chiwetalu and Bernstein Ratner (2003) stated “it is
difficult to achieve the goals of [EBP] if one cannot obtain and interpret the evidence
appropriately” (p. 166-167).

11

Overcoming the Research-to-Practice Gap
To mitigate the effects of the research-to-practice gap and to promote the union of
research and clinical services, various strategies and guidelines are available on how to
effectively utilize EBP (e.g., Gillam & Gillam, 2006; Johnson, 2006). In 2000, Law
proposed an eight-step scheme for transferring research into clinical practice. A summary
of Law’s eight-step scheme can be found in Table 4.

Table 4. Eight-Step Scheme for Transferring Research into Clinical Practice (Adapted
from Law, 2000)
Step 1

Clearly identify the clinical problem.

Step 2

Gather information from research studies about this problem.

Step 3

Ensure that you have adequate knowledge to read and critically analyze
the research studies.

Step 4

Decide if a research article or review is relevant to your clinical problem
in which you are interested.

Step 5

Summarize the information so that it can be easily used in your practice.

Step 6

Define the expected outcomes for the client and their families.

Step 7

Provide education and training to implement the suggested change in
practice.

Step 8

Evaluate the practice, change, and modify (if necessary).

In a 2004 article, Robey presented an adaptation to a five-phase model of clinicaloutcome research, which had previously been used by the broader research community, as
a means of structuring the many forms of research in speech-language pathology and
audiology. This model can be utilized as a guide to EBP by assisting clinicians in
identifying new treatment protocols and appropriately interpreting the available research.
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A summary of each phase, including its purpose, research tasks, and evidence level, can
be found in Table 5.

Table 5. Summary of Robey’s Five-Phase Model for Evaluating Research (Adapted from
Robey, 2004)
Phase
I

Purpose
Selecting
therapeutic
effect,
identifying if
effect is
present, and
estimating the
effect’s
magnitude

II

Exploring the
dimension of
therapeutic
effect and
making
preparation for
conducting
clinical trial

III

Conduct a
clinical trial to
test efficacy

1.
2.
3.
4.
5.
6.

Method(s)
Make point and interval
estimates of effect size
Approximate population
definitions
Approximate treatment
protocol
Estimate appropriate dose
Specify therapeutic effect
Generate/refine hypotheses

1. Determine indications of
efficacy
2. Refine target population
3. Assess therapeutic effect’s
range of utility
4. Refine treatment protocol and
develop administration manual
5. Determine discharge criteria
6. Determine optimal dosage
7. Assess duration of effect
8. Identify measurement
instruments
9. Finalize operational definitions
1. Compare obtained point and
interval estimates of effect size
with estimates produced by
other experiments on the same
or similar problem
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Type(s) of Evidence
Case studies,
discovery-oriented
single-subject studies,
small-group pre-post
studies, &
retrospective studies

Case studies,
discovery-oriented
single-subject studies
(as logical extensions
of Phase I), singlesubject studies,
small-group withineffect studies, casecontrol studies, &
small-group cohortcontrol studies

Parallel-group
designs & singlesubject design studies

Table 5 (Continued). Summary of Robey’s Five-Phase Model for Evaluating ClinicalOutcome Research (Robey, 2004)
Phase
IV

Purpose

Method(s)

Assess the degree 1. Test effectiveness in target
population
to which
therapeutic effect 2. Test effectiveness in specific
is realized in day
sub-populations
to day clinical
3. Test effectiveness under
practice
variations of service-delivery
models

Type(s) of Evidence
Pre- versus poststudies, parallelgroup studies, &
hypothesis-driven
single-subject studies

4. Test effectiveness variants of
treatment protocol
5. Conduct meta-analyses of
efficacy studies
V

Determine who
benefits from the
treatment and at
what cost

1. Assess costs and values in
fiscal and societal terms via
cost-benefit analysis

Cost-effectiveness
studies

Furthermore, Robey (2004) presented an adaptation to the Consolidated Standards
of Reporting Trials (CONSORT) document as a framework for evaluating the scientific
value of a report. Using the CONSORT framework, evaluating quality is determined
through evaluation of threats to internal, external, statistical conclusion, and construct
validities. Therefore, both Robey’s five-phase model for evaluating clinical-outcome
research and the CONSORT document can be used by clinicians to organize research and
optimize use of EBP interventions.
Robey (2004) also claims that the importance of meta-analyses should not be
overlooked during the process of formulating EBP practice guidelines. The author states
“Because a meta-analysis of all studies testing the efficacy of a certain treatment protocol
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is a synthesis of all relevant findings on the question, the results figure prominently in the
formulation of evidence-based practice guidelines” (p. 406). The Cochrane
Collaboration, which consists of 52 review groups, is considered the gold standard of
systematic reviews. Originally created to inform healthcare decision, the Cochrane
Collaboration is now used to inform treatment and intervention decisions in disciplines
other than health, including speech-language pathology. Cochrane’s systematic reviews
synthesize data to provide an overall measure of the effectiveness of a particular
intervention and provide a review of the methodologies that are most appropriate. The
Cochrane Handbook, which provides guidance to authors for the preparation of a
Cochrane Intervention review, can be accessed at http://www.cochrane-handbook.org/.

Limitations of EBP in !eurological Communication Disorders
With the EBP model in hand, speech-language pathologists can methodically
scrutinize the literature, evaluate the quality of the research, and use their clinical
expertise to decide on the appropriateness of a particular treatment approach for a client.
However, the important question remains, how well do clinicians’ perceptions of which
treatment approaches are evidence based match the treatment outcomes in EBP literature?
In this regard, Borden, Harris, and Raphael (2002) stated “our perceptions often match
our expectations rather than what was actually said and heard” (p. 151). We have already
seen that over time speech-language pathologists tend to rely more on personal
experiences and clinical judgment than current research (Zipoli & Kennedy, 2005).
Referring to what Silliman (1999) called the “seeing is knowing” phenomenon, clinicians
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may be more affected by observable outcomes than by published reports. Moreover,
clinicians may be persuaded by commercial propaganda or advertisements and coaxed
into thinking these marketed approaches are indeed evidence based.
Rehabilitation of neurological communication disorders is vulnerable to the use of
therapeutic practices without evidentiary support. Before any attempts to bridge the
research-to-clinical practice gap can be made, we must first have a clear understanding of
the perceptions clinicians are holding of what is and is not evidence based. There have
been several survey studies designed to identify potential barriers to EBP (e.g., Metcalf et
al., 2001) and attitudes toward EBP (e.g., Zipoli & Kennedy, 2005; Vallino-Napoli &
Reilly, 2004). However, few studies have been designed to probe what treatment
approaches to neurogenic communication disorders clinicians are currently implementing
and the rationales behind their implementation. Furthermore, a review of the literature
failed to identify a survey designed to probe the correlation between what clinicians
perceive to be evidence based and what truly is evidence based as measured by support in
the literature. Therefore, the need remains for a survey study probing perceptions of
evidence as they relate to EBP in clinical decision-making. If a disconnect is found
concerning the accuracy of perceptions of evidence and the implementation of EBP,
contributing factors may be identified and addressed.
The primary objective of the current study is to investigate the treatment
approaches clinicians are currently implementing to treat aphasia, and where and how
information is obtained related to each approach. The secondary objective of this study is
to compare the perceived level of evidence for each treatment approach versus the actual
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evidence available in current literature and practice guidelines. Also studied is the
amount of time required for a clinician to first become exposed to an individual treatment
approach and to implement the approach in their regular clinical practices. The overall
goal, therefore, is to examine potential trends within the field of speech-language
pathology relating to role of EBP in the clinical decision-making of aphasia therapy and
the quality of evidentiary support for these decisions.

Research Questions
The current study will address the following research questions:
1. Do current clinicians of neurogenic communication disorders implement
evidence-based practices?
2. Where are clinicians obtaining information regarding the practices they are
implementing?
3. Are the perceptions of what clinicians believe to be evidence-based in accordance
with available practice guidelines?
4. How much time typically passes between when a clinician is first exposed to and
when he/she first implements different treatment approaches?
5. What factors contribute to the lag in time between exposure to and
implementation of treatment approaches?
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CHAPTER TWO:
METHODS
Instrument
The survey, which appears in Appendix A, consists of six sections and was
designed to obtain information about the ways that speech-language pathologists obtain
information and the perceived level of evidence for various treatment approaches for
aphasia. The survey was designed in accordance with the five stages in the development
and completion of a survey as described by Czaja and Blair (2005). These stages include
1) preliminary planning and survey design, 2) pre-testing of the questions, 3) final survey
planning and design, 4) data collection, and 5) data coding and analysis.
Section I of the survey included of 11 questions and probes background
information, including items addressing primary work setting, years of experience,
highest degree earned, percentage of caseload consisting of patients with aphasia, and
specialty credentials earned by participating SLPs.
Section II of the survey was designed to obtain information regarding the
treatment approaches and/or devices clinicians are currently using in the treatment of
aphasia. This section consisted of a list of 18 aphasia treatment approaches, and
respondents were asked to select all of the treatments they have used and/or
recommended within the last year of providing services to patients with aphasia. Space
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was provided for respondents to provide information regarding any additional treatment
approaches that are not included in the survey list. A list of the 18 treatment approaches
included in the survey and a brief description of each can be found in Appendix B.
Section III of the survey was designed to obtain information regarding the
perceived levels of evidence for various aphasia treatment approaches. Using the same
list of treatment approaches as in Section I, this section asked respondents to rate their
perceived levels of evidence for these treatment approaches using a 4-point Likert scale:
1) no evidence, 2) minimal evidence, 3) moderate evidence, or 4) strong evidence.
Section IV of the survey was designed to obtain information regarding clinicians’
primary means of obtaining information for treatment approaches they have used and/or
recommended within the last year. Using the same list of treatment approaches as in
Section I and a numeric value answer key, respondents reported that they 1) learned about
it in graduate school, 2) learned about it at a conference or workshop, 3) learned about it
through an advertisement (e.g., ASHA’s Online Buyer’s Guide, magazine, catalog), 4)
learned about it in a professional magazine (e.g., Advance, Stroke Connection Magazine,
The ASHA Leader), 5) learned about it in a professional journal (e.g., American Journal
of Speech-Language Pathology, Aphasiology, Journal of Speech, Language, and Hearing
Research), 6) a colleague recommended it, or 7) other.
Section V of the survey was designed to obtain information regarding how much
exposure to a particular treatment approach was required by a clinician before they began
implementing the approach in their regular clinical practices. Using the same list of
treatment approaches as in Section I and a numeric value answer key, respondents were
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asked to report the approximate amount of time that passed between when they were first
exposed to and when they first implemented each approach. Respondents reported that
the amount of time was 1) 0-3 months, 2) 4-6 months, 3) 6-9 months, 4) 9-12 months, or
5) >12 months. A follow-up question then probed to identify which variables contributed
to the time lag between exposure to and implementation of treatment approaches.
Respondents reported that the time lag was due to 1) not having the appropriate
client/caseload for the treatment, 2) wanting to learn more about the treatment’s
procedures, 3) limited time for gathering materials for the treatment, 4) materials for the
treatment could not be purchased, 5) desire to review the evidence base for the treatment,
6) desire to ask colleagues’ opinions of the treatment, and/or 7) other.
Section VI of the survey, which consists of two open-ended questions, was
designed to encourage respondents to discuss factors that may facilitate the use of EBP in
their treatment of patients with aphasia. This section also allowed respondents to report
and describe situations which prompted them to seek and implement alternative treatment
approaches for their patient(s) with aphasia.
This survey study has a causal comparative research design. The independent
variables are the survey questions (i.e., demographics questions and questions related to
individual treatment approaches). The dependent variables are the responses to
questions, both qualitative (those responses to open-ended questions) and quantitative
(those numerical responses associated with closed-ended or mutually exclusive
questions). The survey responses were all nominal or open-ended data and were analyzed
descriptively.
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Item Development
A systematic approach was used in the selection of treatments to be presented in
the survey. First, aphasia treatment approaches with a reasonable evidence base were
selected for inclusion in the survey. For the purposes of this study, this level of evidence
was demonstrated by a systematic review of studies that 1) are considered to be Class II
level of evidence or higher and 2) include an adequate number of participants to infer
generalizability. In order to use a practical guideline, published systematic reviews from
the Academy of Neurologic Communication Disorders and Sciences (ANCDS) Evidence
Based Practice Guidelines for the Management of Communication Disorders in
Neurologically Impaired Individuals were reviewed. A summary of these systematic
reviews, including the levels of evidence for the studies reviewed and overall evidentiary
support for the treatment approaches, is presented in Table 6.
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Table 6. Summary of the Levels of Evidence in Systematic Reviews of Various
Treatment Approaches for Aphasia Accessed by the ANCDS
Reference

Bayles et al.
(2006)

Cherney et al.
(2008)

Type of
Treatment

Does the
Review Support
Evidence for
This
Treatment?
Yes;
Simulated
“The feasibility,
presence
pilot, and
therapy
efficacy studies
(SimPres) in
dementia of the support the
Alzheimer type positive effects
of SimPres on
(DAT)
agitated and
withdrawn
behaviors
produced by
individuals with
moderate to
severe DAT” (p.
xix)
ConstraintYes;
induced
“In chronic
language
aphasia, studies
therapy (CILT) provided modest
in aphasia
evidence for
more intensive
treatment and the
positive effects
of CILT” (P.
1282)
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# of
Studies
Reviewed
to Support
EBP
3 studies

5 studies

Level of
Evidence

Study 1: Class II
(Intermediate)
Study 2: Class II
(Intermediate)
Study 3: Class II
(Intermediate)

Study 1: Class II
(Intermediate)
Study 2: Class III
(Weakest)
Study 3: Class II
(Intermediate)
Study 4: Class I
(Highest)
Study 5: Class III
(Weakest)

Table 6 (Continued). Summary of the Levels of Evidence in Systematic Reviews of
Various Treatment Approaches for Aphasia Accessed by the ANCDS
Reference

Type of
Treatment

Hopper et al.
(2005)

Spacedretrieval (SR)
training in
dementia

Does the
Review Support
Evidence for
This
Treatment?
Yes;
Results were
“generally
positive in that
the large
majority of the
participants
learned some or
all of the target
information and
behaviors being
taught” (p. xxxi);
“The results
were
overwhelmingly
positive” (p.
xxxii)
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# of
Studies
Reviewed
to Support
EBP
15 studies

Level of
Evidence

Study 1: Class III
(Weakest)
Study 2: Class III
(Weakest)
Study 3: Class III
(Weakest)
Study 4: Class III
(Weakest)
Study 5: Class III
(Weakest)
Study 6: Class III
(Weakest)
Study 7: Class III
(Weakest)
Study 8: Class III
(Weakest)
Study 9: Class III
(Weakest)
Study 10: Class II
(Intermediate)
Study 11: Class II
(Intermediate)
Study 12: Class II
(Intermediate)
Study 13: Class II
(Intermediate)
Study 14: Class II
(Intermediate)
Study 15: Class II
(Intermediate)

Table 6 (Continued). Summary of the Levels of Evidence in Systematic Reviews of
Various Treatment Approaches for Aphasia Accessed by the ANCDS
Reference

Kennedy et al.
(2005)

Kennedy
(2008)

Type of
Treatment

Does the
Review Support
Evidence for
This
Treatment?
Self-regulation Yes;
in patients with “Several studies
have
TBI
documented the
efficacy and
effectiveness of
intervention
aimed at
improving
problem solving
through
sequences of
steps, including
self-monitoring”
(p. 252)
Executive
Yes;
functions (e.g., “All studies
problem
reported positive
solving,
immediate
planning, and
treatment
organizing) in
outcomes based
TBI
on our
qualitative and
quantitative
analyses” (p. 35)
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# of
Studies
Reviewed
to Support
EBP
10 studies

15 studies

Level of
Evidence

Not specified;
Authors currently
critiquing
evidence

Class I: 5 studies
Class II: 3 studies
Class III: 7
studies

Table 6 (Continued). Summary of the Levels of Evidence in Systematic Reviews of
Various Treatment Approaches for Aphasia Accessed by the ANCDS
Reference

Type of
Treatment

Kim et al.
(2006)

Group
reminiscence
therapy in
dementia

Mahendra et al. Computer(2005)
assisted
cognitive
interventions
(CACIs) in
dementia

Does the
Review Support
Evidence for
This
Treatment?
Yes;
“Provide
preliminary
evidence for the
positive effects
that group RT
can have on
communication
and cognition of
individuals with
dementia” (p.
xxxi)
Inconclusive;
“All three
studies reviewed
were classified
as providing
Class II evidence
in support of the
use of CACIs
with dementia
patients.
However,
considerable
research is
needed before
making stronger
conclusions” (p.
xli)
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# of
Studies
Reviewed
to Support
EBP
6 studies

3 studies

Level of
Evidence

Study 1: Class II
(Intermediate)
Study 2: Class II
(Intermediate)
Study 3: Class II
(Intermediate)
Study 4: Class II
(Intermediate)
Study 5: Class II
(Intermediate)
Study 6: Class II
(Intermediate)
Study 1: Class II
(Intermediate)
Study 2: Class II
(Intermediate)
Study 3: Class II
(Intermediate)

Table 6 (Continued). Summary of the Levels of Evidence in Systematic Reviews of
Various Treatment Approaches for Aphasia Accessed by the ANCDS
Reference

Type of
Treatment

Mahendra et al. Montessori(2006)
based
intervention in
dementia

Does the
Review Support
Evidence for
This
Treatment?
inconclusive;
“Montessori
activities were
more beneficial
than regular or
routine activities
in improving
performance on
cognitive
measures,
engagement
levels, affective
states, and social
interaction.
However, more
information is
necessary
regarding the
nature and
implementation
of regular
activities and
how these differ
from Montessori
activities before
strong
conclusions can
be drawn” (p.
xxii)
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# of
Studies
Reviewed
to Support
EBP
5 studies

Level of
Evidence

Study 1: Class II
(Intermediate)
Study 2: Class II
(Intermediate)
Study 3: Class III
(Weakest)
Study 4: Class III
(Weakest)
Study 5: Class III
(Weakest)

Table 6 (Continued). Summary of the Levels of Evidence in Systematic Reviews of
Various Treatment Approaches for Aphasia Accessed by the ANCDS
Reference

Type of
Treatment

Sohlberg et al.
(2003)

Direct
attention
training in TBI

Sohlberg et al.
(2007)

Use of external
aids for the
management of
memory
disorders in
traumatic brain
injury

Does the
Review Support
Evidence for
This
Treatment?
No;
“Our review
process
highlights the
need for research
that better
described the
specific elements
of attention
training that are
most effective in
particular
contexts and the
outcomes that
result from such
training” (p.
xxxvi)

# of
Studies
Reviewed
to Support
EBP
9 studies

Yes;
“The studies are
universally
supportive of the
general practice
of using external
aids to
compensate for
memory
impairments” (p.
xxii)

21 studies
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Level of
Evidence

Study 1: Class I
(Highest)
Study 2: Class II
(Intermediate)
Study 3: Class I
(Highest)
Study 4: Class I
(Highest)
Study 5: Class II
(Intermediate)
Study 6: Class II
(Intermediate)
Study 7: Class II
(Intermediate)
Study 8: Class II
(Intermediate)
Study 9: Class II
(Intermediate)
Class I: 1 study
Class II: 10
studies
Class III: 10
studies
Class IV: 0
studies
Class V: 0
studies

Table 6 (Continued). Summary of the Levels of Evidence in Systematic Reviews of
Various Treatment Approaches for Aphasia Accessed by the ANCDS
Reference

Type of
Treatment

Ylvisaker et al.
(2007)

Behavioural
intervention
for children
and adults with
behaviour
disorders after
TBI

Zientz et al.
(2007)

Caregiveradministered
active
cognitive
stimulation in
Alzheimer’s
disease (AD)

Does the
Review Support
Evidence for
This
Treatment?
Yes;
“Both traditional
contingency
management
procedures and
positive behavior
support
procedures can
be said to be
evidence-based
treatment
options”
(p. 769)
Yes;
“The three
studies reviewed
provide Class II
evidence to
support the
training of
family caregivers
to administer
active cognitive
stimulation to
individuals with
AD” (p. xxxii)
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# of
Studies
Reviewed
to Support
EBP
65 studies

3 studies

Level of
Evidence

Class I: 2 studies
Class II: 1 study
Class III: 36
studies
Class IV: 26
studies
Class V: 0
studies

Study 1: Class II
(Intermediate)
Study 2: Class II
(Intermediate)
Study 3: Class II
(Intermediate)

Table 6 (Continued). Summary of the Levels of Evidence in Systematic Reviews of
Various Treatment Approaches for Aphasia Accessed by the ANCDS
Reference

Zientz et al.
(2007)

Type of
Treatment

Does the
Review Support
Evidence for
This
Treatment?
Yes;
CaregiverThe studies show
administered
communication “evidence for
education and
strategies in
communication
Alzheimer’s
training of
disease (AD)
family and
professional
caregivers of
individuals with
AD and other
types of
dementia” (p. lx)

# of
Studies
Reviewed
to Support
EBP
7 studies

Level of
Evidence

Study 1: Class I
(Highest)
Study 2: Class II
(Intermediate)
Study 3: Class II
(Intermediate)
Study 4: Class II
(Intermediate)
Study 5: Class II
(Intermediate)
Study 6: Class II
(Intermediate)
Study 7: Class III
(Weakest)

The American Speech-Language-Hearing Association (ASHA) Compendium of
EBP Guidelines and Systematic Reviews was also accessed in order to review evidencebased aphasia treatment approaches. Additional factors affecting clinical decision
making were also reviewed including intensity of treatment, potential effects of formal
versus informal aphasia treatments, and caregiver burden of various treatments. A
summary of these systematic reviews, including the levels of evidence for the studies
reviewed and overall evidentiary support for the treatment approaches, is presented in
Table 7.
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Table 7. Summary of the Levels of Evidence in Systematic Reviews of Various
Treatment Approaches for Aphasia Accessed by the ASHA EBP Compendium
Reference

Type of
Treatment/
Purpose

Bhogal et al.
(2003)

To determine
the
relationship
between
treatment
intensity and
recovery

Does the
Review
Support
Evidence for
This
Treatment?
Yes;
Intense therapy
over a short
amount of time
can improve
outcomes of
speech and
language
therapy for
stroke patients
with aphasia;
“Studies that
demonstrated a
significant
treatment effect
provided 8.8
hours of therapy
per week for
11.2 weeks
versus the
negative studies
that only
provided ~2
hours per week
for 22.9 weeks”
(abstract, p. 1)
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# of Studies
to
Reviewed
to Support
EBP

Level of
Evidence

10 studies

Study 1: Class I
(Highest)
Study 2: Class I
(Highest)
Study 3: Class I
(Highest)
Study 4: Class I
(Highest)
Study 5: Class I
(Highest)
Study 6: Class I
(Highest)
Study 7: Class I
(Highest)
Study 8: Class I
(Highest)
Study 9: Class I
(Highest)
Study 10: Class I
(Highest)

Table 7 (Continued). Summary of the Levels of Evidence in Systematic Reviews of
Various Treatment Approaches for Aphasia Accessed by the ASHA EBP Compendium
Reference

Type of
Treatment/
Purpose

Bhogal et al.
(2003)

To develop
the “more is
better” idea
within the
framework of
aphasia
therapy and
examines
aspects that
may be
combined to
facilitate
recovery

Does the
Review
Support
Evidence for
This
Treatment?
No;
“four studies
demonstrated a
positive impact
of aphasia
therapy and
four studies
demonstrated
no significant
impact of
aphasia therapy
on recovery” (p.
67)
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# of Studies
to
Reviewed
to Support
EBP

Level of
Evidence

8 studies

Study 1: Class I
(Highest)
Study 2: Class I
(Highest)
Study 3: Class I
(Highest)
Study 4: Class I
(Highest)
Study 5: Class I
(Highest)
Study 6: Class I
(Highest)
Study 7: Class I
(Highest)
Study 8: Class I
(Highest)

Table 7 (Continued). Summary of the Levels of Evidence in Systematic Reviews of
Various Treatment Approaches for Aphasia Accessed by the ASHA EBP Compendium
Reference

Type of
Treatment/
Purpose

Greener et al.
(1999)

To determine
1) whether
formal speech
and language
therapy is
more effective
than no
therapy in
improving
expressive
and receptive
language,
2) whether
formal
therapy is
more effective
than nonprofessional
support,
3) whether
nonprofessional
support is
more effective
than no
support,
4) whether
formal
therapy is
more effective
than another
type of
support

Does the
Review
Support
Evidence for
This
Treatment?
Inconclusive;
“speech and
language
therapy
treatment for
people with
aphasia after a
stroke has not
been shown
either to be
clearly effective
or clearly
ineffective
within a
randomized
controlled trial.
Decisions about
management of
patients must
therefore be
based on other
forms of
evidence.
Further research
is required to
find out if
effectiveness of
speech and
language
therapy for
aphasic patients
is effective”
(abstract, p. 1)
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# of Studies
to
Reviewed
to Support
EBP

Level of
Evidence

12 studies

Study 1: Class I
(Highest)
Study 2: Class I
(Highest)
Study 3: Class I
(Highest)
Study 4: Class I
(Highest)
Study 5: Class I
(Highest)
Study 6: Class I
(Highest)
Study 7: Class I
(Highest)
Study 8: Class I
(Highest)
Study 9: Class I
(Highest)
Study 10: Class I
(Highest)
Study 11: Class I
(Highest)
Study 12: Class I
(Highest)

Table 7 (Continued). Summary of the Levels of Evidence in Systematic Reviews of
Various Treatment Approaches for Aphasia Accessed by the ASHA EBP Compendium
Reference

Type of
Treatment/
Purpose

Greener et al.
(2001)

The effect of
drugs on
language
abilities when
given to
people with
aphasia
following a
stroke

Does the
Review
Support
Evidence for
This
Treatment?
Inconclusive;
“We could not
determine if
drug treatment
is more
effective than
speech and
language
therapy. We
could not
determine
whether one
drug is more
effective than
another” (p. 1);
“Further
research is
needed to
explore the
effects of drugs
for aphasia, in
particular
piracetam”
(p. 1)
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# of Studies
to
Reviewed
to Support
EBP

Level of
Evidence

10 studies

Study 1: Class I
(Highest)
Study 2: Class I
(Highest)
Study 3: Class I
(Highest)
Study 4: Class I
(Highest)
Study 5: Class I
(Highest)
Study 6: Class I
(Highest)
Study 7: Class I
(Highest)
Study 8: Class I
(Highest)
Study 9: Class I
(Highest)
Study 10: Class I
(Highest)

Table 7 (Continued). Summary of the Levels of Evidence in Systematic Reviews of
Various Treatment Approaches for Aphasia Accessed by the ASHA EBP Compendium
Reference

Type of
Treatment/
Purpose

Rombough et al.
(2006)

Examines the
literature on
the
burden/strain
experienced
by caregivers
of stroke
patients and
examines the
relationship
between
aphasia and
this
burden/strain

Does the
Review
Support
Evidence for
This
Treatment?
No;
The review
suggests the
lack of research
regarding the
relationship
between
aphasia and
caregiver
burden/strain
and key
initiatives are
needed
including the
development of
an instrument
with
psychometric
properties
appropriate for
assessing this
relationship
(p. 1)
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# of Studies
to
Reviewed
to Support
EBP

Level of
Evidence

14 studies

Quantitative
articles: 12
studies
Mixed design
study: 1 study
Qualitative
study: 1 study

Table 7 (Continued). Summary of the Levels of Evidence in Systematic Reviews of
Various Treatment Approaches for Aphasia Accessed by the ASHA EBP Compendium
Reference

Type of
Treatment/
Purpose

Rombough et al.
(2007)

Review to
determine the
appropriate
design studies
and
instruments
used to assess
quality of life
(QOL) in
caregivers of
stroke
survivors

Does the
Review
Support
Evidence for
This
Treatment?
N/A;
The majority of
caregivers
reviewed were
women and
spouses with
average ages
between 50 and
60 years; Small
sample sizes of
included studies
limit
generalizability
(p. 77)

# of Studies
to
Reviewed
to Support
EBP

Level of
Evidence

9 studies

Study 1: Class III
(Weakest)
Study 2: Class III
(Weakest)
Study 3: Class I
(Highest)
Study 4: Class III
(Weakest)
Study 5: Class I
(Highest)
Study 6: Class III
(Weakest)
Study 7: Class II
(Intermediate)
Study 8: Class I
(Highest)
Study 9: Class III
(Weakest)

The Practice Guidelines of the ANCDS and the ASHA EBP Compendium were
chosen to aid in the selection of treatment approaches for the survey because both are
readily available sources of evidence-based information for clinicians. Both sources are
easily accessible as they do not require payments or university access to view
publications, and they do not require membership to any organizations beyond ASHA.
Therefore, published systematic reviews and practice guidelines may be accessed at these
sources by any clinician who possesses ASHA certification and internet access.
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Based on the review of practice guidelines and systematic reviews presented in the
Practice Guidelines of the ANCDS and ASHA EBP Compendium, a decision was made
to include treatment approaches in the survey that have a reasonable level of evidence.
As previously stated, this level of evidence was demonstrated by a systematic review of
studies that 1) are considered to be Class II level of evidence or higher and 2) include an
adequate number of participants to infer generalizability. Furthermore, the studies
reviewed in each systematic review must be in accordance to support a basic level of
efficacy for the treatment.
Also included in the survey are aphasia treatment approaches that may or may not
be evidence based but are advertised and may be familiar to clinicians. In order to
determine the types of treatments, software, alternative communication devices, and/or
instrumentation to which clinicians treating aphasia may regularly be exposed, several
professional magazines were reviewed for commercial advertisements including
ADVA!CE for Speech-Language Pathologists & Audiologists, Stroke Connection
Magazine, and The ASHA Leader. Additional advertisements were searched in ASHA’s
Online Buyer’s Guide. A basic Google search for the keywords “aphasia treatment
products” and “aphasia treatment approaches” was also conducted in order to determine
which treatments clinicians may access via a commonly-used search engine.
Treatments selected for inclusion in the survey, therefore, met at least one of two
possible inclusion criteria: 1) the treatment met the pre-determined basic level of
evidence and/or 2) the treatment may or may not be supported by evidence but is highly
advertised and easily accessed by clinicians. Therefore, treatment approaches included in
36

the survey are either drawn from a list of evidence-based treatments or drawn from a list
of advertised treatments, with or without an evidence base.
After reviewing ADVA!CE for Speech-Language Pathologists & Audiologists,
Stroke Connection Magazine, The ASHA Leader, and ASHA’s Online Buyer’s Guide, the
18 treatment approaches included in the survey were categorized based on
presence/absence of advertising and evidence base. Three treatment approaches were
categorized as “evidence based and advertised.” Specifically, these treatments included
1) augmentative and alternative communication (AAC), 2) picture naming therapy, and
stimulation approach (e.g., workbooks).
Eleven treatment approaches were categorized as “evidence based and not
advertised.” These treatments included 1) communication partner training (CPT), 2)
constraint-induced aphasia therapy (CIAT), 3) functional communication therapy (FCT),
4) intensive aphasia therapy, 5) melodic intonation therapy (MIT), 6) promoting aphasics’
communicative effectiveness (PACE), 7) response elaboration training (RET), 8)
semantic feature analysis (SFA), 9) sentence production program for aphasia, 10) spacedretrieval training, and 11) treatment for underlying forms (TUF).
Four treatment approaches were categorized as “no/limited evidence base and
advertised.” These treatments included use of 1) computer treatments, 2) Interactive
Metronome® (IM), 3) Sentactics®, and 4) SentenceShaper®. No treatment approach
was categorized as having “no/limited evidence base and not advertised.” A summary of
the categorization of the treatment approaches included in this study is presented in
Table 8.
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Table 8. Treatment Approach Categorization Based on Advertising and Evidence

Evidence Base
+
1.

Advertised

2.

+

3.

1.

.ot
Advertised
--

Augmentative and Alternative
Communication (AAC)
(e.g., DynaVox®; Say-it! SAM
Communicator®)
Picture Naming Therapy
(e.g., picture naming kits)
Stimulation Approach
(e.g., Workbooks)

Communication Partner Training
(CPT) (e.g., Supported
Conversation)
2. Constraint-Induced Aphasia
Therapy (CIAT)
3. Functional Communication
Therapy (FCT)
4. Intensive Aphasia Therapy
5. Melodic Intonation Therapy
(MIT)
6. Promoting Aphasics’
Communicative Effectiveness
(PACE)
7. Response Elaboration Training
(RET)
8. Semantic Feature Analysis (SFA)
9. Sentence Production Program for
Aphasia (formerly HELPSS)
10. Spaced-Retrieval Training (SRT)
11. Treatment for Underlying Forms
(TUF)

.o/Limited Evidence Base
-1.

2.
3.
4.

Computer Treatments
(e.g., Parrot Software®;
Bungalow Software®;
Lingraphica®)
Interactive Metronome ®
Sentactics®
SentenceShaper®

No treatment approaches
identified

Content Validity
Survey pre-testing was conducted in consideration of Czaja and Blair (2005) who
suggested the “benefit of testing seems to come from simply exposing the questionnaire
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to people not involved in its construction,” (p. 6). Following several initial drafts and
revisions of the survey, a precursor to the survey used in this study was piloted to a panel
of three expert reviewers to enhance content validity and improve the utility of the survey.
Two of these reviewers were doctorate-level university faculty members with current
state licensure and the CCC-SLP. The third reviewer was a doctorate-level student within
the Department of Communication Sciences and Disorders at the university where the
survey was developed.
The reviewers provided written and verbal feedback regarding appropriateness of
survey items, representativeness of items with regard to clinical practice patterns, and
suggestions for improving the visual appeal and layout of the instrument. Specifically,
the answer keys for questions 13-15 were moved to the top of the page in order to
improve utility of these questions. The amount of space provided for participants to write
responses to open-ended questions and information related to “other” responses was also
increased. The final survey, which appears in Appendix A, reflects the suggestions
provided by these reviewers.

Participants
Survey respondents met the following criteria: 1) certified speech-language
pathologist and 2) regularly provide services to patients with aphasia. Respondents were
contacted via 1) the e-mail listserv of the American Speech-Language-Hearing
Association Special Interest Division 2, 2) the state representatives’ e-mail listserv of the
National Aphasia Association (NAA) database, and 3) select monthly meetings of the
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Tampa Bay Medical Speech Pathology Association (MESPA). Recruited participants
were working adults ranging from 20 to 60+ years of age. Gender and ethnicity of the
respondents reflect demographics of the profession in this specialty. Overall, it is
estimated that 4,500 potential respondents were contacted.
Recruitment efforts attempted to draw a sample of participants that presumably is
representative of the total population of SLPs providing services to patients with aphasia.
According to Fitz-Gibbon & Morris (1987), a sample size of 30 is considered adequate
for statistical analysis purposes regardless of the size of the group being represented.
Albeit, the larger the sample the better for ensuring that responses adequately represent
the opinions and attitudes of the larger population. According to ASHA, there are
approximately 110,000 ASHA-certified SLPs of which 35% (i.e., 38,500) are employed
in healthcare facilities. According to Krejcie & Morgan’s (1970) table for determining
sample size from a given population, which is based on a formula published by the
research division of the Nation Education Association (NEA), the recommended sample
size for the current study is approximately 379.

Procedure
The surveys were electronically mailed (Appendix C) and/or provided in a hard
copy format to potential respondents. All questionnaires were accompanied by a cover
letter (Appendix D) to briefly explain the purpose of the study, provide a statement of
informed consent, and explain that participant identities would remain anonymous and
responses would be confidential. Participants consisted of those speech-language
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pathologists who return a completed survey. The identities of all participants were kept
anonymous and all responses remain confidential via deletion of clinician names from
surveys and separation of respondent correspondence from surveys.
The de-identified survey data was analyzed and compared to the current literature
base and practice guidelines for the selected treatment approaches. During analysis,
consideration was given to how clinicians are obtaining information on particular
treatment approaches, whether clinician perceptions on evidence-based approaches are
consistent with evidentiary support, and what factors contribute to the time lag between
exposure to and implementation of treatment approaches. Raw data is reported in
Appendix E.

Assumptions
Based on the research questions presented and the survey design implemented,
several assumptions must be made. First, because a survey study relies on a self-report
method of data collection, respondents must be assumed to be accurate reporters of their
own behaviors and perceptions. Second, because the current study is based on a sample
of clinicians providing services to patients with neurogenic communication disorders, it
must be assumed that the sample effect(s) can be generalized to the greater population of
clinicians. Finally, because this research design is descriptive, not explanatory, results
cannot offer insight into potential cause-effect relationships. Therefore, results can only
be assumed to be useful in describing characteristics of rehabilitation professionals as
they relate to EBP.
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CHAPTER THREE:
RESULTS
The role of evidence-based practice (EBP) in the clinical decision-making of
aphasia treatment was examined in the current study. Launching both Web-based and
hard copy versions of an 18-question survey, questions probed clinician perceptions of
the evidence level, primary sources of information, and timeframe of implementation
related to various traditional treatment approaches for aphasia.
Of the estimated 4,500 potential respondents contacted via the American SpeechLanguage-Hearing Association (ASHA) Special Interest Division 2 listserve, the state
representatives’ e-mail listserv of the National Aphasia Association (NAA) database, and
monthly meetings of the Tampa Bay Medical Speech Pathology Association (MESPA)
during the recruitment period, 117 (2.6%) responses were obtained. In an attempt to
ensure the highest quality data possible, each of the 117 completed surveys was reviewed,
and erroneous responses were deleted by the principle investigator with primary
responsibility for the survey. Of the 117 completed surveys, 13 surveys were excluded
from data analysis because the respondents either 1) reportedly do not currently provide
services to patients with aphasia (N = 8) or 2) terminated survey participation after the
first question (N = 5). Therefore, a total of 104 responses were eligible for data analysis.
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Demographics
Section I consisted of 11 questions probing demographic characteristics of survey
respondents. Respondents were all speech-language pathologists (SLP) who currently
provide services to patients with aphasia. Although not required in all states, 93.3% (N =
97) of respondents reported having current state licensure in SLP. Of the 104
respondents, 92.3% (N = 96) were female and 7.7% (N = 8) were male.
The majority of respondents were between 40 and 60 years of age (N = 71,
68.3%). Specifically, the age range of respondents included 10.6% (N = 11) reporting
“20-30 years,” 13.5% (N = 14) reporting “31-40 years,” 35.6% (N = 37) reporting “41-50
years,” 32.7% (N = 34) reporting “51-60 years,” and 7.7% (N = 8) reporting “60+ years.”
The majority of respondents also reported having a master’s degree as the highest degree
earned. Specifically, 71.2% (N = 74) reported earning a master’s degree, 25.9% (N = 27)
reported earning a doctoral degree, and 2.9% (N = 3) reported earning a clinical doctoral
degree.
As medical SLPs, a majority of respondents currently provide services to patients
with aphasia within a hospital (39.4%, N = 41), university/college clinic (37.5%, N = 39),
or rehabilitation center (31.7%, N = 33). Additional settings reported included skilled
nursing facilities (9.6%, N = 10), private or group practice (9.6%, N = 10), and home
health agencies (3.8%, N = 4). A graph depicting the settings where survey respondents
currently provide services can be found in Figure 2.
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Figure 2. Summary of Survey Respondents’ Current Settings of Practice

More than 84% (N = 88) of respondents reported being a member of an ASHA
Special Interest Division (SID). Specifically, 1.9% (N = 2) reported being a member of
SID 1: Language Learning and Education, 76.9% (N = 80) reported being a member of
SID 2: Neurophysiology and Neurogenic Speech and Language Disorders, 9.6% (N = 10)
reported being a member of SID 3: Voice and Voice Disorders, 1.9% (N = 2) reported
being a member of SID 4: Fluency and Fluency Disorders, 1.0% (N = 1) reported being a
member of SID 5: Speech Science and Orofacial Disorders, 5.8% (N = 6) reported being
a member of SID 10: Issues in Higher Education, 11.5% (N = 12) reported being a
member of SID 11: Administration and Supervision, 8.7% (N = 9) reported being a
member of SID 12: Augmentative and Alternative Communication, 27.9% (N = 29)
reported being a member of SID 13: Swallowing and Swallowing Disorders, 3.8%
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(N = 4) reported being a member of SID 14: Communication Disorders and Sciences in
Culturally and Linguistically Diverse (CLD) Populations, 12.5% (N = 13) reported being
a member of SID 15: Gerontology, and 1.9% (N = 2) reported being a member of SID 16:
School-Based Issues.
No respondent reported being a member of SID 6: Hearing and Hearing
Disorders: Research and Diagnostics, SID 7: Aural Rehabilitation and Its Instrumentation,
SID 8: Hearing Conservation and Occupational Audiology, or SID 9: Hearing and
Hearing Disorders in Childhood. Members of SID 2 were expected to be a large majority
of the respondents as SID 2 was the primary source of participant recruitment. A
summary of respondents’ SID membership can be found in Table 9.

Table 9. Summary of Survey Respondents’ ASHA SID Membership
ASHA
SID Membership
SID 1, Language Learning & Education
SID 2, Neurophysiology/Neurogenic Speech & Language Disorders
SID 3, Voice & Voice Disorders
SID 4, Fluency & Fluency Disorders
SID 5, Speech Science & Orofacial Disorders

2
80
10
2
1

%
of Respondents
1.9%
76.9%
9.6%
1.9%
1.0%

SID 6, Hearing & Hearing Disorders: Research & Diagnostics
SID 7, Aural Rehabilitation & Its Instrumentation
SID 8, Hearing Conservation & Occupational Audiology
SID 9, Hearing & Hearing Disorders in Childhood
SID 10, Issues in Higher Education
SID 11, Administration & Supervision
SID 12, Augmentative & Alternative Communication
SID 13, Swallowing & Swallowing Disorders
SID 14, CSD in Culturally & Linguistically Diverse Populations
SID 15, Gerontology
SID 16, School-Based Issues
None

0
0
0
0
6
12
9
29
4
13
2
16

0%
0%
0%
0%
5.8%
11.5%
8.7%
27.9%
3.8%
12.5%
1.9%
15.4%
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Eleven respondents (10.6%) reported having specialty credentials, including nine
(8.7%) respondents with Board Certification in Neurogenics (ANCDS), one (1.0 %)
respondent with Board Recognition in Fluency and Fluency Disorders, and one (1.0 %)
respondent with Board Recognition in Swallowing and Swallowing Disorders.
Additional credentials reported by respondents included Brain Injury Specialist
Certification (N =2), Multiple Sclerosis Specialist Certification (N = 1), and Lee
Silverman Voice Treatment (LSVT) Certification (N = 1).
Respondents varied widely in reporting an approximate percent of their caseload
consisting of patients with aphasia. Of the 104 respondents, 16.3% (N = 17) reported
having “less than 10%” patients with aphasia, 25.0% (N = 26) reported having “About
25%” patients with aphasia, 26.9% (N = 28) reported having “Between 33% - 66%”
patients with aphasia, 8.7% (N = 9) reported having “About 75%” patients with aphasia,
and 23.1% (N = 24) reported having “More than 75%” patients with aphasia. A graph
depicting survey respondents’ estimated percentages of caseload consisting of patients
with aphasia can be found in Figure 3.
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Figure 3. Summary of Survey Respondents’ Approximate Percentage of Caseload
Consisting of Patients with Aphasia

As would be expected, survey respondents reported varying years of practice as an
SLP. A majority of respondents, however, were experienced SLPs as 42.3% (N = 44)
reported having “20+ years” experience as an SLP. Additionally, 2.9% (N = 3) reported
“less than 2 years” experience, 13.5% (N = 14) reported “2-5 years” experience, 11.5%
(N = 12) reported “6-10 years” experience, 15.4% (N = 16) reported “11-15 years”
experience, and 14.4% (N = 15) reported “16-20 years” experience. A graph depicting
survey respondents’ years of experience can be found in Figure 4.
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Figure 4. Summary of Survey Respondents’ Years of Experience as an SLP

Consistent with years of practice as an SLP, a majority of respondents reported
having “20+ years” of direct clinical experience with patients with aphasia (39.4%, N =
41). Additionally, 2.9% (N = 3) reported “less than 2 years” experience with aphasia,
14.4% (N = 15) reported “2-5 years” experience with aphasia, 15.4% (N = 16) reported
“6-10 years” experience with aphasia, 14.4% (N = 15) reported “11-15 years” experience
with aphasia, and 13.5% (N = 14) reported “16-20 years” experience with aphasia. A
graph depicting survey respondents’ years of direct clinical experience with patients with
aphasia can be found in Figure 5.
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Figure 5. Summary of Survey Respondents’ Years of Direct Clinical Experience with
Aphasia

Aphasia Treatment Approaches
Survey Question 12 asked “Which of the following treatment approaches have
you used or recommended in the past year?” The three most frequently reported
treatments were Communication Partner Training (CPT) (N = 74, 71.2%), Functional
Communication Therapy (FCT) (N = 72, 69.2%), and Promoting Aphasics’
Communicative Effectiveness (PACE) (N = 70, 67.3%). The three least frequently
reported treatments were Interactive Metronome® (IM) (N = 5, 4.8%), SentenceShaper®
(SSR) (N = 5, 4.8%), and Sentactics® (N = 2, 1.9%). Table 10 is a list of all treatment
approaches included in the survey in terms of frequency of reported use. Figure 6
provides a visual interpretation of the reported frequency of use for these treatments.
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Table 10. Reported Frequency of Use for Treatment Approaches Listed in Survey
Treatment Approaches

.

Communication Partner Training (CPT)
Functional Communication Therapy (FCT)
Promoting Aphasics’ Communicative Effectiveness
(PACE)
Augmentative and Alternative Communication (AAC)
Stimulation Approach
Melodic Intonation Therapy (MIT)
Semantic Feature Analysis (SFA)
Picture Naming Therapy
Computer Treatments
Intensive Aphasia Therapy
Response Elaboration Training (RET)
Sentence Production Program for Aphasia (formerly
HELPSS)
Spaced-Retrieval Training (SRT)
Constraint-Induced Aphasia Therapy (CIAT)
Treatment for Underlying Forms (TUF)
Interactive Metronome® (IM)
SentenceShaper® (SSR)
Sentactics®
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74
72
70

% of
Respondents
71.2%
69.2%
67.3%

65
59
55
53
45
40
40
33
31

62.5%
56.7%
52.9%
51.0%
43.3%
38.5%
38.5%
31.7%
29.8%

31
24
12
5
5
2

29.8%
23.1%
11.5%
4.8%
4.8%
1.9%

Figure 6. Reported Frequency of Use for Treatment Approaches Listed in Survey

Respondents also had the option of selecting “other” and reporting additional
treatment approaches not explicitly listed in the survey. Respondents reported 22
additional treatment approaches used or recommended in the past year. Of these 22
additional approaches, the treatments reported by multiple respondents were Anagram,
Copy, and Recall Therapy (ACRT), also referred to as Copy and Recall Treatment
(CART), (N = 7, 6.7%), Oral Reading for Language in Aphasia (ORLA) (N = 4, 3.8%),
Amer-Ind (N = 2, 1.9%), and script writing (N = 2, 1.9%). Eighteen additional treatment
approaches were also reported, each by a single respondent. Table 11 is a list of the 22
additional treatments reported in the survey in terms of frequency of reported use. Figure
7 provides a visual interpretation of the reported frequency of use for these treatments.
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Table 11. Reported Frequency of Use for “Other” Treatment Approaches Listed in
Survey
“Other” Treatment Approaches Reported
Anagram, Copy, and Recall Therapy (ACRT/CART)
Oral Reading for Language in Aphasia (ORLA)
Amer-Ind
Script Writing
Book Connection™
Cognitive-Linguistic Approaches
Cognitive Underpinnings
Cued Verb Treatment
English as a Second Language (ESL) Websites
Fluent Generative Naming
Gesture and Verbal Training (GVT)
Mapping
Multiple Oral Re-Reading (MOR)
Phonological Components Analysis (PCA)
Picture Communication Boards
Problem-Solving Approach to Spelling
Repetition Priming
Semantic Phonetic Cueing Hierarchy
Simply Smart Aphasia Therapy (SSAT)
Treatment of Aphasic Perseveration (TAPS)
Visual Action Therapy (VAT)
Verb Network Strengthening Treatment (VNeST)

.
7
4
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

%
6.7%
3.8%
1.9%
1.9%
1.0%
1.0%
1.0%
1.0%
1.0%
1.0%
1.0%
1.0%
1.0%
1.0%
1.0%
1.0%
1.0%
1.0%
1.0%
1.0%
1.0%
1.0%

Prior to launching the current survey, the 18 treatment approaches included in the
survey were categorized based on presence/absence of advertising and evidence base.
Based on the review of practice guidelines and systematic reviews presented in the
Practice Guidelines of the ANCDS and ASHA EBP Compendium a level of evidence was
demonstrated by a systematic review of studies that 1) are considered to be Class II level
of evidence or higher and 2) include an adequate number of participants to infer
generalizability. Also included in the survey are aphasia treatment approaches that may
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or may not be evidence based but are advertised to clinicians. Several professional
magazines were reviewed for commercial advertisements and a basic Google search for
the keywords “aphasia treatment products” and “aphasia treatment approaches” was also
conducted in order to determine which treatments clinicians may access via a commonlyused search engine.
Upon respondent reporting of 22 additional treatment approaches, the
categorization was updated to reflect these additional treatments. Fifteen additional
treatment approaches were reported and subsequently categorized as “evidence based and
not advertised.” Specifically, these treatments included 1) Anagram, Copy, and Recall
Therapy (ACRT), 2) Amer-Ind, 3) cognitive-linguistic approaches, 4) cued verb
treatment, 5) fluent generative naming, 6) Gesture and Verb Training (GVT), 7) mapping,
8) Multiple Oral Re-Reading (MOR), 9) Oral Reading for Language in Aphasia (ORLA),
10) Phonological Components Analysis (PCA), 11) picture communication boards, 12)
script writing, 13) semantic phonetic cueing hierarchy, 14) Treatment of Aphasic
Perseveration (TAPS), and 15) Visual Action Therapy (VAT).
Of the additional treatment approaches reported and considered to not have a
significant evidence base, two additional treatment approaches were reported and
categorized as “no/limited evidence base and advertised.” These treatments included the
use of 1) Book Connection™ and 2) English as a second language (ESOL) Websites.
Five additional treatment approaches were reported and categorized as “no/limited
evidence base and not advertised.” These treatments included 1) cognitive
underpinnings, 2) problem-solving approach to spelling, 3) repetition priming, 4) Simply
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Smart Aphasia Therapy (SSAT), and 5) Verb Network Strengthening Treatment
(VNeST). A summary of treatment approach categorization, including the additional
treatments identified by respondents, can be found in Table 12.
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Table 12. Summary of Treatment Approach Categorization, Including Additional
Treatments Identified During Survey Completion, Based on Advertising and Evidence

Advertised
+

.ot
Advertised
˗˗

Evidence Base
+
1. Augmentative and Alternative
Communication (AAC) (e.g., DynaVox®;
Say-it! SAM Communicator)
2. Picture Naming Therapy (e.g., picture
naming kits)
3. Stimulation Approach

1. Anagram, Copy, & Recall Therapy
(ACRT)
2. Amer-Ind
3. Cognitive-Linguistic Approaches
4. Communication Partner Training (CPT)
5. Constraint-Induced Aphasia Therapy
(CIAT)
6. Cued Verb Treatment
7. Fluent Generative Naming
8. Functional Communication Therapy
(FCT)
9. Gesture and Verbal Training (GVT)
10. Intensive Aphasia Therapy
11. Mapping
12. Melodic Intonation Therapy (MIT)
13. Multiple Oral Re-Reading (MOR)
14. Oral Reading for Language in Aphasia
(ORLA)
15. Phonological Components Analysis (PCA)
16. Picture Communication Boards
17. Promoting Aphasics’ Communicative
Effectiveness (PACE)
18. Response Elaboration Training (RET)
19. Script writing
20. Semantic Feature Analysis (SFA)
21. Semantic Phonetic Cueing Hierarchy
22. Sentence Production Program for Aphasia
23. Spaced-Retrieval Training (SRT)
24. Treatment of Aphasic Perseveration
(TAPS)
25. Treatment for Underlying Forms (TUF)
26. Visual Action Therapy (VAT)
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1.
2.
3.
4.
5.
6.

.o/Limited Evidence Base
-Book Connection™
Computer Treatments
English as a Second
Language (ESL) Websites
Interactive Metronome ®
Sentactics®
SentenceShaper®

1. Cognitive Underpinnings
2. Problem-Solving Approach
to Spelling
3. Repetition Priming
4. Simply Smart Aphasia
Therapy (SSAT)
5. Verb Network
Strengthening Treatment
(VNeST)

Perceived Levels of Evidence
Survey Question 13 asked “How strong do you believe the evidence to be for each
approach you selected in Question 12?” It is important to note that not all respondents
reporting to have used or recommended a treatment in the past year provided a perceived
level of evidence for that treatment. Similarly, some respondents reported perceived
levels of evidence for treatments which they did not report using or recommending in the
past year. Therefore, only data for treatments reported to have been used or
recommended in the past year (Question 12) were included in data analysis.
The treatment approaches perceived as having “minimal” evidence by the
majority of respondents (i.e., ≥50%) included stimulation approach (56.1%), picture
naming therapy (50.0%), and the Sentence Production Program for Aphasia (50.0%). Of
the 22 additional treatment approaches not explicitly included in the survey but reported
to be used by respondents, Oral Reading for Language in Aphasia (ORLA) (50.0%) and
Amer-Ind (100%) are also perceived as having “minimal evidence.” A summary of the
treatment approaches perceived as having “minimal evidence” can be found in Table 13.

Table 13. Treatment Approaches Perceived as Having “Minimal Evidence”
Treatment Approaches Rated
“Minimal Evidence”

. / Total

Stimulation Approach
Picture Naming Therapy
Sentence Production Program for Aphasia
Other
Oral Reading for Language in Aphasia
Amer-Ind

23 / 41
18 / 36
13 / 26

% of Respondents
Rating
“Minimal Evidence”
56.1%
50.0%
50.0%

2/4
1/1

50.0%
100%
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The treatment approaches perceived as having “moderate” evidence by the
majority of respondents (i.e., ≥50%) included Treatment for Underlying Forms (TUF)
(81.8%), Semantic Feature Analysis (SFA) (73.9%), Spaced-Retrieval Training (SRT)
(57.7%), Promoting Aphasics’ Communicative Effectiveness (PACE) (52.1%),
Communication Partner Training (CPT) (50.8%), and Constraint-Induced Aphasia
Therapy (CIAT) (50.0%). Of the additional treatment approaches reported to be used by
respondents, script writing (100%) and Anagram, Copy, and Recall Therapy (ACRT)
(50.0%) are also perceived as having “moderate evidence.” A summary of the treatment
approaches perceived as having “moderate evidence” can be found in Table 14.

Table 14. Treatment Approaches Perceived as Having “Moderate Evidence”
Treatment Approaches Rated
“Moderate Evidence”

. / Total

Treatment for Underlying Forms (TUF)
Semantic Feature Analysis (SFA)
Spaced-Retrieval Training (SRT)
Promoting Aphasics’ Communicative
Effectiveness (PACE)
Communication Partner Training (CPT)
Constraint-Induced Aphasia Therapy
(CIAT)
Other
Scripts
Anagram, Copy, and Recall Therapy
(ACRT/CART)

9 / 11
34 / 46
15 / 26
25 / 48

% of Respondents
Rating
“Moderate Evidence”
81.8%
73.9%
57.7%
52.1%

32 / 63
8 / 16

50.8%
50.0%

2/2
3/6

100%
50.0%

Each treatment approach had a small percentage of respondents perceiving it to
have “no/limited evidence” and a small percentage of respondents perceiving it to have
57

“strong evidence.” No treatment approach had a majority of respondents perceiving it to
have “no/limited evidence.” The only treatment approach perceived as having a “strong”
level of evidence was the Interactive Metronome® (IM) with 100% of respondents rating
it as having “strong evidence.” However, it is important to note that only two
respondents provided a level of evidence for this treatment approach.
All remaining treatment approaches had a majority of respondents (i.e., ≥50%)
reporting between “minimal evidence” to “moderate evidence.” Specifically, these
treatment approaches included SentenceShaper® (100%), Melodic Intonation Therapy
(MIT) (88.6%), computer treatments (86.7%), augmentative and alternative
communication (AAC) (84.9%), Functional Communication Therapy (FCT) (82.5%),
Response Elaboration Training (RET) (76.0%), and intensive aphasia therapy (72.2%). A
summary of the treatment approaches perceived as having “minimal” or “moderate”
evidence can be found in Table 15.

Table 15. Treatment Approaches Perceived as Having “Minimal” to “Moderate”
Evidence
Treatment Approaches Rated
“Minimal” to “Moderate” Evidence

. / Total

SentenceShaper®
Melodic Intonation Therapy (MIT)
Computer Treatments
Augmentative and Alternative
Communication (AAC)
Functional Communication Therapy
(FCT)
Response Elaboration Training (RET)
Intensive Aphasia Therapy

4/4
39 / 44
26 / 30
45 / 53

% of Respondents Rating
“Minimal” or “Moderate”
Evidence
100%
88.6%
86.7%
84.9%

52 / 63

82.5%

19 / 25
39 / 54

76.0%
72.2%
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Sources of Information
Survey Question 14 asked “What has been your primary means of attaining
information regarding each approach you selected in Question 12?” It is important to
note that not all respondents reporting to have used or recommended a treatment in the
past year provided a primary source of information for that treatment. Similarly, some
respondents reported sources of information for treatments that were not reported to be
used or recommended in the past year. Therefore, only sources of information for
treatments reported to have been used or recommended in the past year (Question 12)
were included in data analysis.
The most frequently reported sources of information were professional journals
(N = 180, 31.6%), graduate school (N = 174, 30.5%), conferences (N = 88, 15.4%), and
colleague (N = 76, 13.3%). The least frequently reported sources of information were
magazines (N = 9, 1.6%) and advertisements (N = 4, 0.7%). Respondents selected
“other” as their primary sources of information in 6.8% of responses (N = 39). However,
due to the limitations of the survey software used, no additional information was able to
be obtained regarding these additional sources of information. A summary of the
frequency of sources of information reported can be found in Figure 7.
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Figure 7. Summary of Frequency of Sources of Information Reported

The treatment approaches reported as having “Graduate School” as the primary
source of information by the majority of respondents (i.e., ≥50%) included stimulation
approach (70.5%), picture naming therapy (65.6%), and Melodic Intonation Therapy
(MIT) (53.3%). A summary of the treatment approaches reportedly learned in graduate
school can be found in Table 16.

Table 16. Treatment Approaches Learned in Graduate School
Treatment Approaches With
“Graduate School”
As Primary Source of Information
Stimulation Approach
Picture Naming Therapy
Melodic Intonation Therapy (MIT)

. / Total

31 / 44
21 / 32
24 / 45
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% of Respondents Selecting
“Graduate School”
As Primary Source
70.5%
65.6%
53.3%

The treatment approaches reported as having “Professional Journal” as the
primary source of information by the majority of respondents (i.e., ≥50%) included
Treatment For Underlying Forms (TUF) (83.3%), Semantic Feature Analysis (SFA)
(55.6%), Constraint-Induced Aphasia Therapy (CIAT) (50.0%), and SentenceShaper®
(50.0%). Of the additional treatment approaches reported to be used by respondents,
script writing (50.0%) and Anagram, Copy, and Recall Therapy (ACRT) (50.0%) were
also reported to be learned through professional journals. A summary of the treatment
approaches reportedly learned through professional journals can be found in Table 17.

Table 17. Treatment Approaches Learned Through Professional Journals
Treatment Approaches With
“Professional Journal”
As Primary Source of Information
Treatment For Underlying Forms (TUF)
Semantic Feature Analysis (SFA)
Constraint-Induced Aphasia Therapy
(CIAT)
SentenceShaper®
Other
Anagram, Copy, and Recall Therapy
Script Writing

. / Total

10 / 12
25 / 45
8 / 16

% of Respondents Selecting
“Professional Journal”
As Primary Source
83.3%
55.6%
50.0%

2/4

50.0%

2/4
1/2

50.0%
50.0%

Both “advertisement” and “magazine” were infrequently selected as the primary
source of information. The only treatment approaches with any respondent reporting
“advertisement” as their primary means of attaining information included computer
treatments (N = 3, 9.4%) and intensive aphasia therapy (N = 1, 3.1%). The only
treatment approaches with any respondent reporting “magazine” as their primary source
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of information included Communication Partner Training (CPT) (N = 2, 3.2%),
Functional Communication Therapy (FCT) (N = 2, 3.3%), Promoting Aphasics’
Communicative Effectiveness (PACE) (N = 1, 2.2%), Semantic Feature Analysis (SFA)
(N = 2, 4.4%), computer treatments (N = 1, 3.1%), and Constraint-Induced Aphasia
Therapy (CIAT) (N = 1, 6.3%).

Exposure Prior to Use
Survey Question 15 asked “Looking back, how much time would you estimate
passed between when you first learned of each approach and when you first used it in
practice?” It is important to note that not all respondents reporting to have used or
recommended a treatment in the past year provided a time period for that treatment.
Similarly, some respondents reported time periods for treatments that they did not
indicate as using or recommending in the past year. Therefore, only time periods for
treatments reported to have been used or recommended in the past year (Question 12)
were included in data analysis.
Based on results of Question 15, it appears as though clinicians implement
treatment approaches rather quickly after learning the protocols and gathering the
necessary materials. Overall, respondents reported that they implemented most of the
treatment approaches included in the survey within “0-3 months” of exposure of each
approach. Treatments reportedly implemented within “0-3 months” of exposure by a
majority of respondents (i.e., ≥50%) included picture naming therapy (84.6%),
stimulation approach (80.0%), Functional Communication Therapy (FCT), (74.1%),
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Communication Partner Training (CPT) (63.2%), Constraint-Induced Aphasia Therapy
(CIAT) (61.5%), computer treatments (60.7%), Semantic Feature Analysis (SFA)
(60.5%), Promoting Aphasics’ Communicative Effectiveness (PACE) (60.0%), SpacedRetrieval Training (SRT) (59.1%), Sentence Production Program for Aphasia (57.1%),
Response Elaboration Training (RET) (50.0%), and Sentactics® (50.0%). Of the
additional treatment approaches reported by respondents, Anagram, Copy, and Recall
Therapy (ACRT) (100%), Oral Reading for Language in Aphasia (ORLA) (100%), and
script writing (100%) were also reported to be used within “0-3 months” of exposure. A
summary of the treatments reportedly used within three months can be found in Table 18.

Table 18. Treatment Approaches Implemented Within Three Months of Exposure
Treatment Approaches Reported to be
Implemented Within “0-3 Months” of Exposure

./
Total

Picture Naming Therapy
Stimulation Approach
Functional Communication Therapy (FCT)
Communication Partner Training (CPT)
Constraint-Induced Aphasia Therapy (CIAT)
Computer Treatments
Semantic Feature Analysis (SFA)
Promoting Aphasics’ Communicative Effectiveness
(PACE)
Spaced-Retrieval Training (SRT)
Sentence Production Program for Aphasia
Response Elaboration Training (RET)
Sentactics®
Other
Anagram, Copy, and Recall Therapy (ACRT)
Oral Reading for Language in Aphasia (ORLA)
Scripts

22 / 26
32 / 40
40 / 54
36 / 57
8 / 13
17 / 28
23 / 38
24 / 40

% of Respondents
Selecting “0-3
Months”
84.6%
80.0%
74.1%
63.2%
61.5%
60.7%
60.5%
60.0%

13 / 22
12 / 21
12 / 24
1/2

59.1%
57.1%
50.0%
50.0%

3/3
3/3
1/1

100%
100%
100%
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Although the remaining treatment approaches did not have a majority of
respondents (i.e., ≥50%) reporting implementation within “0-3 months” of exposure, a
substantial number of respondents did report “0-3” months for these treatments. These
treatments included augmentative and alternative communication (AAC) (49.0%),
intensive aphasia therapy (48.1%), Melodic Intonation Therapy (MIT) (39.5%), and
Treatment for Underlying Forms (TUF) (30.0%). The only treatments with a significant
number of respondents not reporting implementation within “0-3 months” were
Interactive Metronome® (50% reporting “4-6 months” and 50% reporting “6-9 months”)
and SentenceShaper® (33.3% reporting “4-6 months,” “9-12 months,” and “>12
months”).
Survey Question 16 asked “What factors have contributed to the time lag between
exposure to and use of treatment approaches?” The most frequently reported response
was “Did not have appropriate client/caseload for the treatment” with 59.6% (N = 62) of
respondents selecting this reason. The least frequently reported response was “Materials
for the treatment could not be purchased” with 13.5% (N = 14) of respondents selecting
this reason. Additional factors reported to contribute to the time lag between exposure
and use included “Wanted to learn more about the procedures of the treatment” (N = 36,
34.6%), “Wanted to review the evidence base for the treatment” (N = 28, 26.9%), “Time
required to gather materials necessary for the treatment” (N = 27, 26.0%), and “Wanted to
ask colleagues’ opinions of the treatment” (N = 21, 20.2%). A summary of factors
reported to contribute to the time lag between exposure to and implementation of
treatment approaches can be found in Figure 8.
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Figure 8. Summary of Factors Reported to Contribute to the Time Lag Between Exposure
and Implementation of Treatment Approaches for Aphasia

Implementation
Section VI consisted of two open-ended questions (Questions 17 and 18) allowing
respondents to provide unrestricted explanations related to their use of EBP. Before
responses could be coded for trend analysis purposes, responses had to be broken down
into comments related to separate ideas. Following a preliminary review of the
responses, a panel of three expert reviewers developed coding guidelines in order to
enhance inter-judge reliability. Two of these reviewers were doctorate-level university
faculty members with current state licensure and the CCC-SLP. The third reviewer was
the principle investigator of this study and a master’s-level student within the Department
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of Communication Sciences and Disorders at the university where the survey was
developed. Based on the panel’s discussion, coding rules were developed as follows:
1) Comments were to be broken up only at sentence boundaries, which included a
period followed by a capital letter, a comma followed by a capital letter, or no
punctuation but two continuous phrases with the second phrase beginning with a
capital letter.
2) Sentences were to be broken up (as defined above) when each sentence seemed to
address a different topic.
3) More than one continuous sentence that included cohesive ties or other intersentential markers that linked the topic across sentences were to be preserved as
one thematic statement.
4) Single sentences that included lists of items marked by commas were not to be
broken up.
Following establishment and implementation of these coding rules, inter-judge
reliability in comment dissection reached 100%. Ultimately, 80 comments were
identified for Question 17 and 79 comments were identified for Question 18.
The same three judges then independently established preliminary trends related
to each question. Preliminary trends were discussed by all three reviewers and a
consensus was reached on final master trends for coding regarding each question. Using
these master trends, each judge independently assigned one alphabetic code to each
comment. Upon review, if two of the three judges assigned the same code to a comment,
that code was accepted as the trend identified. If all three judges provided a different
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code for a comment, the comment was discussed in further detail until an agreement was
reached. Three comments required further discussion, and due to the ambiguity of these
comments were eliminated from further analysis.
Survey Question 17 asked “What would facilitate your increased use of evidencebased practice related to your patients with aphasia?” Although the wording varied
considerably among responses, the panel of three judges identified five master trends
repeated throughout responses. These trends can be found in Table 19.

Table 19. Identified Trends and Corresponding Subtrends for Question 17
Master Trends
Increased ease of access to information

Need for practice-based evidence

Allocation of financial resources

Lack of time

Subtrends
1) Need for Web-based access
2) Difficulty accessing information since
leaving graduate school
1) Need for practice-based research
2) Need for evidence related to specific
populations
3) Need for more practice guidelines
4) Need for standard protocols
1) Lack of funding
2) Lack of financial resources for materials
3) Limited resources
1) Limited time to research evidence base
2) Work setting time constraints

Non-codable/irrelevant comments

The trend most frequently supported by respondents’ comments was a desire for
increased ease of access to information. Of the 80 comments identified for this question,
36 (45%) comments reflected a desire for improved accessibility to evidence-based
information. Subtrends which reflected this trend included a desire for free access to
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information, a need for more Web-based access, desire for broader dissemination of
information regarding specific treatment approaches, a desire for synthesized evidencebased reviews, and difficulty accessing evidence-based information since leaving
graduate school.
In support of this trend, one respondent reported a desire for “easy and free access
to meta-analyses of treatment approaches that include both report of efficacy, step-by-step
instructions for implementing including suggestions for measuring both acquisition and
impact data.” Another respondent reported the need for “having the information available
from reputable sources in a format other than journal articles, which can be time
consuming to read and interpret.”
The second most frequently reported trend was a need for practice-based
evidence. Of the 80 comments identified, 23 (28.8%) comments reflected the need for
practice-based evidence. Subtrends associated with this trend included a need for
research applicable to “real world” situations and specific populations, development of
evidence-based standard protocols, and development of more practice guidelines. For
example, one respondent reported a desire for “more studies which incorporate
individuals who have complex medical histories than those which are typically presented
in the studies which inform evidence-based practice.” Another respondent reported a
need for “greater specificity in published studies as to the protocols followed in
treatment.”
Consistent with a review of the literature regarding barriers to EBP, several
respondents reported the allocation of financial resources and lack of professional time to
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impede their use of EBP. Eight (10.0%) comments reflected a lack of funding for
continuing education, lack of financial resources for materials, or limited resources for
EBP implementation. Similarly, seven (8.8%) comments reflected limited time to
research the evidence base as well as other work setting time constraints. One respondent
stated that time limitations require him/her to depend on “articles that interpret and
summarize the research to help me determine whether to try something versus being
given the details of the study” but acknowledges that “depending on someone else to
determine if it is a solid study and findings is risky.”
Suggestions for the facilitated use of evidence-based practice related to the
treatment of patients with aphasia included free Webinars, a more user-friendly ASHA
Website, and development of an easily digested compendium of evidence, such as a
handbook, manual, or Web-based source. One respondent creatively suggested a
“Therapy of the Month” e-mail that could briefly and succinctly describe a treatment’s
protocol and evidence base.
Finally, six (7.5%) comments were considered to be non-codable or irrelevant
comments. Such comments included statements that the individual already implements
EBP in their clinical decision making as well as statements describing the current
credentials or awards of continuing education (ACE) held by the individual. A summary
of the trend analysis for Question 17 can be found in Table 20. A visual representation of
this trend analysis can be found in Figure 9.
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Table 20. Summary of Trends Identified as Affecting Use of EBP with Patients with
Aphasia
Trend Category
Increased ease of access to
information
Need for practice-based information
Allocation of financial resources
Lack of time
Non-codable/Irrelevant

Comments Identified
36

% of Comments
45.0%

23
8
7
6

28.8%
10.0%
8.8%
7.5%

Figure 9. Summary of Trends Identified as Affecting Use of EBP with Patients with
Aphasia

Survey Question 18 asked respondents to “Describe situations which prompted
you to seek and implement alternative approaches for patients with aphasia.” Originally,
79 comments were identified for this question. However, three comments could not be
agreed upon during the coding process due to ambiguity and were eliminated from
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analysis. The panel of three judges identified six master trends repeated throughout
responses. These trends can be found in Table 21.

Table 21. Identified Trends and Corresponding Subtrends for Question 18
Master Trends
Lack of treatment success
Challenging diagnoses

Interest in a new treatment
approach
Client need

Clinician expertise

Subtrends
1)
2)
1)
2)
3)
1)
2)
1)
2)
3)
1)

Treatment failure
Wanted to make treatment more functional
Unique/rare diagnoses
Specific populations
Chronic aphasia
Interest following a review of the evidence
Interest following conference/workshop/colleague
Need for individualized treatment
Client dissatisfied with previous treatment outcome
Client preference
Clinician’s desire to improve own skill level

Non-codable/Irrelevant

The trend which most frequently prompted the respondents to seek and implement
an alternative treatment for aphasia was lack of treatment success. Of the 76 comments
identified for this question, 28 (36.8%) comments reflected a need for an alternative
approach because of treatment failure, lack of anticipated success, or a need to make
treatment more functional for the patient. For example, one respondent commented,
“When I have a client who is not responding to ‘traditional’ treatment, I will seek out
journal articles about treatments related to the client’s needs.”
Another frequently reported trend which prompted an alternative treatment
approach was simply client need which included client dissatisfaction, client preference,
varying needs based on the recovery process, and need for individualization of treatment.
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Of the 76 comments, 19 (25.0%) reflected client-driven reasons for alternative treatment
implementation. For example, one respondent stated, “I tailor my treatments to the client
needs and personalize according to the individual’s background; When I do not have the
approach that addresses the deficit and client, I seek other approaches.” Another
respondent described using an alternative treatment when treatment is based on
“transitioning the client to personally relevant participation and activity based tasks that
need task analysis and situational modification.”
Several respondents also reported comments which reflected a challenging
diagnosis as the catalyst for implementing alternative treatment approaches for aphasia.
Specifically, 13 (17.1%) comments described using alternative approaches for unique
and/or rare diagnoses and specific populations of patients with unique needs. For
example, one respondent commented, “When I see a client with a less frequent diagnosis,
e.g. PPA, I often review the literature and assure that I have considered all options and
alternatives.” Many comments also reflected the need to seek alternative treatments for
patients with chronic aphasia. Specific populations which prompted alternative
treatments included bilingual or multicultural patients, patients with limited education,
and hearing and/or visually impaired patients with aphasia.
Five (6.6%) respondents provided a comment reflecting implementation of an
alternative treatment approach following exposure to a new treatment. Interest was
typically initiated following a literature review indicating promise in a treatment or after
exposure to the treatment through a conference, workshop, or colleague. For example,
one respondent state, “Sometimes it was the lure of something new and different that
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prompted some experimentation; Sometimes the mention of a new approach by a
colleague or mentor prompted the change.”
Five (6.6%) comments indicated that clinician expertise was the driving force
behind implementation of an alternative treatment. Comments generally reflected the
clinician’s desire to improve their own skill level through knowledge of alternative
approaches, such as “I want to be as effective as I can to help my patients.”
Finally, 6 (7.9%) comments were considered to be non-codable or irrelevant
comments. Such comments included statements that reflected respondents’ confusion of
the question and statements that did not relate to the question. A summary of the trend
analysis for Question 17 can be found in Table 22. A visual representation of trend
analysis can be found in Figure 10.

Table 22. Summary of Trends Identified as Prompting Alternative Treatments
Approaches to Aphasia
Trend Category
Lack of treatment success
Client need
Challenging diagnoses
Interest in a new treatment approach
Clinician expertise
Non-codable/Irrelevant

Comments Identified
28
19
13
5
5
6
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% of Comments
36.8%
25.0%
17.1%
6.6%
6.6%
7.9%

Figure 10. Summary of Trends Identified as Prompting Alternative Treatment
Approaches to Aphasia
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CHAPTER FOUR:
CONCLUSION AND DISCUSSION
The current study investigated issues regarding the use of evidence-based practice
(EBP) in the clinical decision-making of aphasia therapy. Web-based and hard copy
versions of an 18-question survey were created in an attempt to build our understanding
of the potential research-to-practice gap in the treatment of neurological communication
disorders. The current study addressed the following research questions:
1. Do current clinicians of neurogenic communication disorders implement
evidence-based practices?
2. Where are clinicians obtaining information regarding the practices they are
implementing?
3. Are the perceptions of what clinicians believe to be evidence-based in accordance
with available practice guidelines?
4. How much time typically passes between when a clinician is first exposed to and
when he/she first implements different treatment approaches?
5. What factors contribute to the lag in time between exposure to and
implementation of treatment approaches?

75

Results of the current study extend the findings of previous studies regarding the
perceptions and implementation of EBP within aphasia therapy. Results indicate that
many of the common treatment approaches for aphasia currently in practice are evidence
based. However, a research-to-practice gap exists as clinicians are not reportedly
implementing many additional treatment approaches also supported by evidence.
Similarly, clinicians’ perceptions of what is evidence based are not always in accordance
with current practice guidelines. Clinicians appear to rely on professional journals,
graduate school training, and professional conferences as their primary sources of
evidence-based information. It does not appear as though advertising significantly affects
clinicians’ decision making in treatment selection. Furthermore, clinicians tend to
implement new or alternative treatment approaches rather quickly after exposure to the
treatment. Possible contributing factors and clinical implications of these findings are
discussed below.

Response Rate
According to Blair and Czaja (2005), “The questionnaire is the indispensible
means by which the opinions, behaviors, and attributes of respondents are converted into
data,” (p.122). However, survey research has a history of being plagued by poor response
rates. According to Babbie & Rubin (2000), a response rate of 50% is considered
adequate for analysis and reporting purposes, a response rate of 60% is considered good,
and a response rate of 70% is considered very good.
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Of the estimated 4,500 potential respondents contacted via the American SpeechLanguage-Hearing Association (ASHA) Special Interest Division 2 listserve, the state
representatives’ e-mail listserv of the National Aphasia Association (NAA) database, and
monthly meetings of the Tampa Bay Medical Speech Pathology Association (MESPA)
during the recruitment period, 117 responses were obtained. This corresponds with a
response rate of approximately 2.6%. Although this response rate is considerably below
the recommended response rate of Babbie & Rubin (2000), the demographics of the
current study parallels that of the ASHA 2009 Health Care Survey. Therefore, the
decision was made to analyze the data in an attempt to answer the research questions
proposed in the current study.
Factors that may have contributed to this low response rate include e-mails going
directly to “junk mail,” respondents not recognizing the sender and deleting the
recruitment e-mail, clinicians not responding to the survey within the data collection time
period, and clinicians forgetting to return to the survey link after receiving the recruitment
e-mail. Participation may have been improved by sending a second recruitment e-mail.

Demographic Representation
Respondents of the current study appear to be representative of the greater
medical speech-language pathology (SLP) community. The demographic composition of
survey respondents in the current study reflects the demographic composition of medical
SLPs in the United States as reported in the ASHA 2009 Health Care Survey. The ASHA
Health Care Survey is a biennial report probing current issues affecting SLPs working in
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health care, such as caseload, shortages, salaries, and productivity (Brown, 2009). Both
the ASHA 2009 Health Care Survey and the current survey, therefore, recruited similar
participants as clinicians working in health care settings are the primary providers of
rehabilitation services to patients with aphasia.
Of the 2,064 SLPs (a response rate of 54.6%) who completed the ASHA 2009
Health Care Survey, 95% of respondents were female and 5% were male, similar to the
gender distribution of the current study (i.e., 92% female, 8% male). In accordance with
the primary employment facilities reported by respondents of the current study,
respondents of the ASHA 2009 Health Care Survey reported clinics (29%), skilled
nursing facilities (23%), and general medical hospitals (20%) as the facilities where most
of the respondents worked. The majority of respondents to ASHA’s survey reported
having a master’s degree, and the mean age of SLPs who participated in the survey was
44. This is consistent with the education level and age range of the majority of
participants in the current study. The mean years of experience reported by ASHA survey
respondents was 15 years, slightly less than was reported in the current study (i.e., 42%
reporting 20+ years experience).
The current study did not probe responses related to salary basis, ethnicity, race,
population density, or geographic distribution and, therefore, could not be compared to
these demographic characteristics of ASHA survey respondents. However, since the
current survey was electronically sent to SLPs throughout the United States, it is assumed
that additional demographic characteristics would reflect the demographic composition of
the greater medical SLP community.
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The clinical findings of the current study are discussed below as they relate to the
research questions proposed and the current evidence base. Additionally, the scope and
limitations of the current study are discussed. Finally, future directions for research are
recommended.

Current Implementation of Evidence-Based Treatments
Research Question 1 asked “Do current clinicians of neurogenic communication
disorders implement evidence-based practices?” Of the treatment approaches listed in the
survey, the three most frequently reported treatments were Communication Partner
Training (CPT), Functional Communication Therapy (FCT), and Promoting Aphasics’
Communicative Effectiveness (PACE). All three of these treatments meet the
predetermined level of evidence as demonstrated by a systematic review of studies that 1)
are considered to be Class II level of evidence or higher and 2) include an adequate
number of participants to infer generalizability. Furthermore, every treatment reported by
a majority of respondents (i.e., >50%) to have been used or recommended within the past
year met this study’s criteria for having an evidence base.
Given Robey’s (1998) meta-analysis, stimulation approach is considered
evidence-based for the purposes of this study. However, there are some concerns
regarding whether or not this approach is truly evidence based as stimulation therapy is
poorly defined. Unlike other treatments, stimulation therapy lacks specific procedures,
and it is unclear as to what actually constitutes stimulation therapy. It remains
questionable whether using various workbook exercises really holds true to the important
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components of a stimulation approach (i.e., exposing patients to tasks that will
“stimulate” functioning of compromised linguistic modalities).
Unfortunately, seven treatment approaches to aphasia that are considered evidence
based were not reported to have been used or recommended in the past year by a majority
of respondents. Specifically, these treatments included intensive aphasia therapy, picture
naming therapy, Response Elaboration Training (RET), Sentence Production Program for
Aphasia (formerly HELPSS), Spaced-Retrieval Training (SRT), Constraint-Induced
Aphasia Therapy (CIAT), and Treatment for Underlying Forms (TUF).
Although each of these treatments has empirical data to support their use, these
treatments do not appear to be commonly used treatments for aphasia in current practice.
Ironically, with the exception of picture naming therapy and Sentence Production
Program for Aphasia (SPPA), respondents perceive these treatments as having a moderate
amount of evidence. This prompts the question: If clinicians perceive these treatments to
be evidence based, why are they not implementing them in their clinical practices?
Possible reasons for non-use of evidence-based treatments may include: the facility by
which the clinician is employed does not own the necessary materials for the treatment,
limited financial resources to purchase required materials, or lack of an appropriate
candidate for the treatment. Clinicians may also be relying on personal experiences and
continuing to use treatments they have found effective rather than attempting additional
treatments. Furthermore, because many respondents indicated graduate school as a
primary source of information, non-use of these treatments may reflect the limited
exposure to these treatments during their graduate training programs.
80

Interestingly, with the exception of stimulation therapy materials, none of the
advertised treatments explicitly included in the survey (i.e., Interactive Metronome ®,
Sentactics®, SentenceShaper®) were reported to be used or recommended by a majority
of respondents. Similarly, advertised computer treatments (e.g., Parrot Software®,
Bungalow Software®, Lingraphica®) were also not used or recommended by a majority.
Therefore, it does not appear that clinicians are highly persuaded by advertising to
implement commercially available aphasia treatments. However, because several
respondents indicated a lack of financial resources as a deterrent from attempting
alternative treatment approaches, it may be that clinicians are not using these advertised
products due to financial barriers rather than the perception of the evidence base for these
products. Although many of these products offer user testimonials or provide financial
compensation to spokespersons within the field, they lack empirical data to be considered
evidence based.
Four additional treatment approaches not included in the survey were reported to
have been used or recommended by multiple respondents in the past year including
Anagram, Copy, and Recall Therapy (ACRT), Oral Reading for Language in Aphasia
(ORLA), Amer-Ind, and script writing. All four of these treatments were classified as
having an evidence base and are not advertised. In contrast, all additional treatments
reported to have been used or recommended by a single respondent (i.e., cognitive
underpinnings, problem-solving approach to spelling, repetition priming, Simply Smart
Aphasia Therapy, Verb Network Strengthening Treatment, Book Connection™, and
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English as a Second Language Websites) are considered to have no/limited evidence base
and are a mixture of advertised products and non-advertised treatments.
Interest in EBP has increased significantly in the past three decades (Zipoli &
Kennedy, 2005). This is particularly true in the past 10 years with the creation of
evidence-based sources of information such as the ASHA EBP Compendium and the
Academy of Neurologic Communication Disorders and Sciences (ANCDS) compendium
of practice guidelines. ASHA has also endorsed EBP at the graduate training level by
promoting use of the Knowledge and Skills Acquisition (KASA) summary form.
However, has a push for use of EBP changed the clinical decision-making in aphasia
therapy? Is there a difference in the treatments used by clinicians practicing 10 years or
less?
Preliminary findings of the current study support the idea that the majority of nonevidence based treatments for aphasia are primarily implemented by clinicians practicing
10 years or more. Specifically, Book Connection™, computer treatments (e.g., Parrot
Software, Bungalow Software, Lingraphica), English as a second language (ESL)
website, Interactive Metronome® (IM), Sentence Shaper®, cognitive underpinnings,
problem-solving approach to spelling, and Simply Smart Aphasia Therapy (SSAT) are
primarily used by clinicians with 10 or more years of direct experience with patient’s with
aphasia. Furthermore, no respondent practicing 2 years or less reported using any nonevidence based treatment. This may reflect emphasis of EBP by graduate training
programs, or it may simply reflect the fact that beginning clinicians participating in the
study have not yet been exposed to these non-evidence based treatments.
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In summary, clinicians of neurogenic communication disorders are implementing
evidence-based treatment approaches. However, many additional evidence-based
treatments (e.g., constraint-induced aphasia therapy, spaced-retrieval training, intensive
aphasia therapy) are not reportedly used in current practices by a majority of respondents.
Furthermore, advertised aphasia treatments and products were also not used or
recommended by a majority of respondents. The majority of non-evidence based
treatments for aphasia are primarily implemented by clinicians practicing 10 years or
more.

Primary Sources of Information
Research Question 2 asked “Where are clinicians obtaining information regarding
the practices they are implementing?” The most frequently reported source of
information was professional journals, which may reflect clinicians’ desire to remain
current with the literature and to incorporate evidence-based treatments into clinical
practices. The second most frequently reported source of information was graduate
school. This may reflect the slow moving evolution of clinical practices of aphasia
treatment as the majority of respondents had 10 or more years of clinical experience and,
therefore, were assumed to have been out of graduate school for at least this long. This
may also reflect clinicians’ failure to self-evaluate and/or modify clinical practices based
upon more current evidence.
Conferences were also frequently reported as a source of information regarding
treatment approaches. This is not surprising given the continuing education (CE)
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requirements to maintain state and ASHA certification. Similarly, many respondents
reported colleagues as a primary source of information. This would be expected as
clinicians spend much of their professional time collaborating with colleagues and
making recommendations to each other. Unfortunately, fellow colleagues may not be the
most reliable sources of evidence-based information, and clinicians should be cautious in
employing recommended treatment approaches which have not been researched.
The least frequently reported sources of information were magazines and
advertisements. Products and treatments advertised in professional magazines and other
SLP publications may or may not be evidence based. Few products have endured
rigorous clinical research to support the claims made in their testimonials. In the current
study, the treatment approaches with any respondent reporting “advertisement” as their
primary means of attaining information included computer treatments and intensive
aphasia therapy. The treatment approaches with any respondent reporting “magazine” as
their primary source of information included Communication Partner Training (CPT),
Functional Communication Therapy (FCT), Promoting Aphasics’ Communicative
Effectiveness (PACE), Semantic Feature Analysis (SFA), computer treatments, and
Constraint-Induced Aphasia Therapy (CIAT). In light of the fact that magazines and
advertisements were infrequently selected as sources of information, it does not appear
that current clinicians are relying on these sources in guiding their clinical decisionmaking in aphasia treatment.
Several respondents also selected “other” as their primary source of obtaining
information. However, due to the limitations of the survey software used, no additional
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information was able to be obtained regarding these additional sources of information. It
would be interesting to probe for additional information regarding what these “other”
sources of information are and if these sources reflect EBP.
Because respondents cited professional journals, graduate school, and conferences
as their primary sources of information, the dissemination of evidence-based information
may be best achieved by capitalizing on these sources. For example, graduate training
programs could be designed to not only provide students with the best available scientific
evidence but could require students to demonstrate ability to apply research to clinical
decision-making. As previously mentioned, the creation of ASHA’s Knowledge and
Skills Acquisition (KASA) summary form has encouraged universities to develop
graduate programs that meet this requirement.
Because many respondents indicated professional conferences as a primary source
of clinical information, clinicians may benefit from selecting continuing education (CE)
courses which include scientific evidence to support the therapeutic approaches
presented. In some situations, conferences are funded by companies whose products lack
empirical evidence or whose presenters are biased toward products, services, or practices.
Therefore, ASHA provides clinicians with indicators of evidence-based CE courses.
While participating in a course or presentation, ASHA recommends clinicians ask
themselves several questions including 1) Is peer reviewed research provided that
supports and/or contradicts the rationale for the course content?, 2) Where do the studies
included in the course fall in terms of level of evidence and study quality?, and 3) Is the
presenter combining his/her own personal expertise with the best available evidence to
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guide the course? Best practices suggest that clinicians appropriately match interventions
to populations served. Finally, it is recommended that clinicians identify which concepts
are rooted in published evidence and which are supported by personal experiences
(ASHA, 2009).

Perceptions of Evidence
Research Question 3 asked “Are the perceptions of what clinicians believe to be
evidence-based in accordance with available practice guidelines?” Based on the results
of the survey, some evidence-based treatments for aphasia are accurately perceived as
having considerable levels of evidence, while many other evidence-based treatments are
not perceived as favorably. Eight treatment approaches were perceived as having a
moderate amount of evidence. These treatments include Treatment for Underlying Forms
(TUF), Semantic Feature Analysis (SFA), Spaced-Retrieval Training (SRT), Promoting
Aphasics’ Communicative Effectiveness (PACE), Communication Partner Training
(CPT), Constraint-Induced Aphasia Therapy (CIAT), script writing, and Anagram, Copy,
and Recall Therapy (ACRT). Participating, clinicians are accurate in their perception of
these treatments as they are supported by the evidence as producing functional outcomes.
In contrast, many additional treatments are also supported by research but were
not perceived as being evidence based by respondents. For example, picture naming
therapy, Sentence Production Program for Aphasia, Oral Reading for Language in
Aphasia (ORLA), and Ameri-Ind were perceived as having minimal evidentiary support,
which may underrate the value of these treatments when compared to practice guidelines.
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This research question may be negatively affected by the statistical phenomenon
of regression toward the mean. Survey research with ordinal questions, such as many
questions included in the current survey, can be affected by regression toward the mean as
measurements tend to be closer to the center of the distribution. In this study, it seems as
though respondents tended to rate treatments as having a minimal-to-moderate level of
evidence and withheld from rating treatments as having no or strong levels of evidence.
Regression toward the mean may help to explain why most of the treatments were rated
near the center of the scale. Therefore, findings must be interpreted with caution as to
why evidence-based treatments (e.g., intensive aphasia therapy, Functional
Communication Therapy) and treatments with limited evidence (e.g., SentenceShaper®,
computer treatments) were all perceived as having minimal-to-moderate levels of
evidence.

Exposure Prior to Implementation
Research Question 4 asked “How much time typically passes between when a
clinician is first exposed to and when he/she first implements different treatment
approaches?” Having a better understanding of the timeline surrounding implementation
of aphasia treatment allows us to better understand just how much exposure to an
approach clinicians need before attempting the approach in their own practices. Findings
of the current study support the idea that clinicians tend to implement treatment
approaches rather quickly after learning of its protocols and gathering the necessary
materials. Overall, respondents reported that they implemented almost all of the
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treatment approaches included in the survey within “0-3 months” of learning of each
approach. The treatments not reported to be implemented within “0-3 months” by a
majority of respondents were Interactive Metronome® and SentenceShaper®. The
participating clinicians reported varying timeframes prior to implementation for these two
treatments.
Although the survey asked respondents to indicate factors that have contributed to
the lag in time between exposure and implementation, respondents were not required to
indicate which factors corresponded with which treatments. However, many respondents
reported a lag in time due to the amount of time required to gather materials and the
inability to purchase materials. Both the Interactive Metronome® and SentenceShaper®
are commercially available aphasia treatments which require specific materials to be
purchased in order to implement the treatment. Therefore, the time required to gather or
purchase the necessary materials may have resulted in a longer lag in time between
exposure and implementation for these two treatments, thus providing a possible
explanation for the variability.
Because current findings reveal that clinicians tend to implement aphasia
treatments within a few months of learning about them, this brings up the question of why
are clinicians implementing approaches so quickly? Furthermore, because it appears that
the learning-to-implementing turnaround time occurs within three months, are clinicians
thoroughly reviewing the evidence base prior to use? Possible factors influencing quick
implementation include a desire to attempt the treatment before the procedures involved
are forgotten and excitement about a new treatment prompting implementation. These
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possible reasons are supported by respondents’ comments regarding interest in a new
approach following a review of the literature indicating promise in a treatment or after
learning of the treatment through a conference, workshop, or colleague.

Factors Delaying Implementation
Research Question 5 asked “What factors contribute to the lag in time between
exposure to and implementation of treatment approaches?” Findings of the current study
fail to support an extended lag in time between exposure and implementation.
Participating clinicians typically implemented treatments within three months of learning
of their procedures. However, respondents identified potential factors that could delay
implementation. The most frequently reported response was not having the appropriate
client/caseload for the treatment. This may reflect clinicians’ adherence to candidacy
requirements for treatment approaches as they do not seem to attempt a newly learned
approach with patients not fitting the treatment’s criteria. Additional reasons for a lag
between exposure and implementation identified by this study included a desire to learn
more about the approach, a desire to review the evidence base, and a desire to ask
colleagues’ opinions regarding the treatment. These may reflect clinicians’ desire to
obtain information from several sources as part of their clinical decision-making. Despite
the financial barriers to implementing EBP as indicated in the literature and reported by
respondents of the current study, the least frequently reported response was not having the
materials for the treatment.
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Limitations of the Research
No research design is without limitations, and this study is no exception. A
common problem in survey research is a high nonresponse rate resulting in a threat to
internal validity. According to Schiavetti & Metz (2002), “if the nonresponse rate is high,
the researcher may have a biased sample, a sample that may not be representative of the
population of interest, and a sample of responders who are quite different, on important
dimensions, from individuals who failed to respond” (p. 293). In order to promote
responses, researchers can implement various strategies including assuring respondent
confidentiality and designing a short, unambiguous, and easy to complete instrument. All
of these measures were adopted in the present study.
According to the ASHA 2009 Health Care Survey, “not only is it typically the
case that some individuals who receive a survey do not complete it (unit nonresponse), it
is likewise true that some who return theirs do not answer every question (item
nonresponse) and thus do not qualify for inclusion in portions of a report,” (ASHA, 2009,
p. 4). This was the case in the current survey as many respondents selected a treatment
approach implemented and/or recommended in the past year but did not provide
responses to the follow up questions regarding the selected treatment. Therefore, certain
responses were excluded from analysis because they did not answer a question at all or
because their answer disqualified them (e.g., providing a perceived level of evidence for a
treatment approach that was not selected as implemented or recommended within the last
year.)
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It is also important to remember that a survey instrument is only as good as the
questions it asks. A serious threat to internal validity is related to the adequacy of the
survey instrument. By pilot testing the survey instrument in the current study, revisions
were able to be made to account for ambiguous questions, questions failing to directly
address the issue under study, and questions leading to biased responses.
Although internet-based survey research has many advantages (e.g., convenience,
ease of administration, ease of data collection), a disadvantage of internet-based research
when compared to other descriptive research designs, such as interviews or focus groups,
is that it is limited in the depth of information that can be obtained. For example, a
survey is limited in its ability to probe for more or different information based upon
participant responses (Schiavetti & Metz, 2002). Surveys are also limited to obtaining
only verbal descriptions of respondents’ opinions and actions and cannot account for
nonverbal information such as body language, eye contact, or rapport between the
respondent and the interviewer.

Future Research
Although ASHA and many practicing SLPs recognize the importance of EBP, the
present study supports a research-to-practice gap in the implementation of evidence-based
aphasia treatments and their perceived levels of evidence. The preliminary conclusions of
the current study extend the findings of previous surveys in the study of EBP in
communication sciences and disorders including barriers and facilitators of EBP.
However, we are far from having a comprehensive understanding of the attitudes and
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perceptions of EBP held by clinicians and the role these play in clinical-decision making
related to aphasia therapy.
Further investigation, including a larger sample, may prove beneficial in
extending our understanding of the research-to-practice gap. It is recommended that data
be obtained regarding the “other” sources of information indicated by respondents of the
current study and if these sources reflect EBP. Similarly, in addition to information on
the timeframe between exposure and implementation, our profession could benefit from
having a better understanding of the type of exposure required. For example, how many
encounters with a treatment approach are required to initiate implementation? Is a
demonstration or observable changes in functional outcome necessary, or is simply
reading about the approach (e.g., journal or magazine article) enough to initiate a
clinician’s attempt at using the approach?
In addition to survey research, a logical next step would be obtaining descriptive
data. For example, as a follow-up to the current study, it is recommended that future
studies investigate EBP via field research. By going directly to clinical settings,
researchers could investigate practice patterns by observing decision making. It is
recommended that chart data also be reviewed to document which treatments clinicians
are using and for which patients. Finally, focus groups may prove crucial in providing
insight into attitude and perceptions of aphasia treatment approaches via nonverbal
information (e.g., body language and eye contact).
Since ASHA’s inception of Knowledge and Skills Acquisition (KASA) in 2005,
graduate training programs have been required to incorporate EBP into the curricula of
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emerging clinicians. However, the potential long-term effect(s) of a focus on EBP in
graduate training is unknown. It is recommended that future research probe how the
implementation of KASA standards has impacted the perceptions of EBP in clinicians
who have received graduate training since 2005, and whether or not these changes in
curriculum affect their clinical practices outside of the academic arena. Furthermore,
research could probe how the implementation of KASA standards may change clinician’s
perceptions of EBP over time. We have already seen that over time speech-language
pathologists tend to rely more on personal experiences and clinical judgment than current
research (Zipoli & Kennedy, 2005). Perhaps clinicians who received graduate training
since 2005 will demonstrate different patterns of reliance on current research, or they may
rely on different sources of information as part of their clinical decision-making.
The field of communication sciences and disorders as a whole could benefit from
increased use of EBP, particularly within medical speech pathology where patients’
quality of life is of paramount importance. Sources such as the ASHA EBP Compendium
and the ANCDS can provide clinicians with practice guidelines for the management of
communication disorders in neurologically impaired individuals. It is of the utmost
importance that SLPs not only incorporate professional expertise but also recognize the
role of best research evidence and patient preferences in our clinical decision-making for
patients with aphasia.
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Appendix A: Web-Based and Hard Copy Survey Questions
SECTION I: Demographics
1. Do you currently see patients with aphasia as part of your caseload?
a) Yes
b) No
2. If yes, approximately what percentage of your caseload consists of patients with
aphasia?
a) Less than 10%
b) About 25%
c) Between 33% - 66%
d) About 75%
e) More than 75%
3. Please indicate the age range in which your chronological age falls:
a) 20-30 years
b) 31-40 years
c) 41-50 years
d) 51-60 years
e) 60+ years
4. Please indicate your gender:
a) Male
b) Female
5. Do you have a current state license in Speech-Language Pathology?
a) Yes
b) No
6. Are you a member of any ASHA Special Interest Division? (Circle all that apply):
a) None
b) ASHA Special Interest Division 1, Language Learning & Education
c) ASHA Special Interest Division 2, Neurophysiology and Neurogenic Speech &
Language Disorders
d) ASHA Special Interest Division 3, Voice & Voice Disorders
e) ASHA Special Interest Division 4, Fluency & Fluency Disorders
f) ASHA Special Interest Division 5, Speech Science & Orofacial Disorders
g) ASHA Special Interest Division 6, Hearing and Hearing Disorders: Research &
Diagnostics
h) ASHA Special Interest Division 7, Aural Rehabilitation & Its Instrumentation
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Appendix A: (Continued)
i) ASHA Special Interest Division 8, Hearing Conservation & Occupational
Audiology
j) ASHA Special Interest Division 9, Hearing & Hearing Disorders in Childhood
k) ASHA Special Interest Division 10, Issues in Higher Education
l) ASHA Special Interest Division 11, Administration & Supervision
m) ASHA Special Interest Division 12, Augmentative & Alternative Communication
n) ASHA Special Interest Division 13, Swallowing & Swallowing Disorders
(Dysphagia)
o) ASHA Special Interest Division 14, Communication Disorders & Sciences in
Culturally and Linguistically Diverse (CLD) Populations
p) ASHA Special Interest Division 15, Gerontology
q) ASHA Special Interest Division 16, School-Based Issues
7. Do you have any specialty credentials? (Circle all that apply):
a) Board Certified in Neurogenics, Academy of Neurologic Communication
Disorders & Sciences (ANCDS)
b) Board Recognized Specialist in Child Language
c) Board Recognized Specialist in Fluency & Fluency Disorders
d) Board Recognized Specialist in Swallowing & Swallowing Disorders
8. Highest degree earned:
a) Master’s degree
b) Doctoral degree
c) Clinical doctoral degree
d) Other (please indicate) _____________
9. How many years have you practiced as a Speech-Language Pathologist?
a) Less than 2 years
b) 2-5 years
c) 6-10 years
d) 11-15 years
e) 16-20 years
f) 20+ years
10. How many years have you had direct clinical experience with patients with aphasia?
a) Less than 2 years
b) 2-5 years
c) 6-10 years
d) 11-15 years
e) 16-20 years
f) 20+ years
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Appendix A: (Continued)
11. Please indicate the setting in which you currently see patients with aphasia?
a) Hospital
b) Skilled nursing facility
c) College / university clinic
d) Rehabilitation center
e) Private or group practice
f) Home health agency
g) Other (please specify) _____________
SECTION II: Aphasia Treatment Approaches
12. Which of the following treatment approaches have you used or recommended in the
past year?
Treatment Approaches

Functional Communication Therapy
Intensive Aphasia Therapy
Semantic Feature Analysis
Augmentative and Alternative Communication
(e.g., Dynavox®; Say-it! SAM Communicator®)
Spaced-Retrieval Training
PACE (Promoting Aphasics’ Communicative
Effectiveness)
Picture Naming Therapy
Constraint-Induced Aphasia Therapy
Interactive Metronome®
Communication Partner Training (e.g., Supported
Conversation; Conversational Coaching)
Sentactics®
Melodic Intonation Therapy
Sentence Production Program for Aphasia
Treatment for Underlying Forms
Stimulation Approach (e.g., Workbook exercises)
Response Elaboration Training
Computer Treatments (e.g., Parrot Software®;
Bungalow Software®; Lingraphica®)
Sentence Shaper®
Other (please specify)
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Please indicate the treatment
approaches you have used or
recommended in the past year
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Appendix A: (Continued)
SECTION III: Perceived Levels of Evidence
13. How strong do you believe the evidence to be for each approach you selected in
Question 12?
Answer Key
1 = No evidence
2 = Minimal evidence
3 = Moderate evidence
4 = Strong evidence

Treatment Approaches

Rate the level of evidence for each
approach you selected? (Please use
the answer key provided)

Functional Communication Therapy
Intensive Aphasia Therapy
Semantic Feature Analysis
Augmentative and Alternative
Communication (e.g., Dynavox®; Say-it!
SAM Communicator®)
Spaced-Retrieval Training
PACE (Promoting Aphasics’ Communicative
Effectiveness)
Picture Naming Therapy
Constraint-Induced Aphasia Therapy
Interactive Metronome®
Communication Partner Training (e.g.,
Supported Conversation; Conversational
Coaching)
Sentactics®
Melodic Intonation Therapy
Sentence Production Program for Aphasia
(formerly HELPSS)
Treatment for Underlying Forms
Stimulation Approach (e.g., Workbook
exercises)
Response Elaboration Training
Computer Treatments (e.g., Parrot Software®;
Bungalow Software®; Lingraphica®)
Sentence Shaper®
Other (please specify)
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SECTION IV: Sources of Information
14. What has been your primary means of attaining information regarding each approach?
Answer Key
1 = I learned about it in graduate school
2 = I learned about it at a conference or workshop I attended
3 = I learned about it through an advertisement (e.g., ASHA’s Online Buyer’s Guide, magazine, catalogue)
4 = I learned about it in a professional magazine (e.g., Advance, Stroke Connection Magazine, The ASHA Leader)
5 = I learned about it in a professional journal (e.g., American Journal of Speech-Language Pathology)
6 = A colleague recommended it
7 = Other (please specify)

Treatment Approaches

Functional Communication Therapy
Intensive Aphasia Therapy
Semantic Feature Analysis
Augmentative and Alternative
Communication (e.g., Dynavox®; Say-it!
SAM Communicator®)
Spaced-Retrieval Training
PACE (Promoting Aphasics’
Communicative Effectiveness)
Picture Naming Therapy
Constraint-Induced Aphasia Therapy
Interactive Metronome®
Communication Partner Training (e.g.,
Supported Conversation)
Sentactics®
Melodic Intonation Therapy
Sentence Production Program for Aphasia
(formerly HELPSS)
Treatment for Underlying Forms
Stimulation Approach (e.g., Workbook
exercises)
Response Elaboration Training
Computer Treatments (e.g., Parrot
Software®; Bungalow Software®;
Lingraphica®)
Sentence Shaper®
Other (please specify)
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Appendix A: (Continued)
SECTION V: Exposure Prior to Use
15. Looking back, how much time would you estimate passed between when you first
learned of each approach and when you first used it in practice?
Answer Key
1 = 0-3 months
2 = 4-6 months
3 = 6-9 months
4 = 9-12 months
5 = >12 months

Treatment Approaches

Functional Communication Therapy
Intensive Aphasia Therapy
Semantic Feature Analysis
Augmentative and Alternative
Communication (e.g., Dynavox®; Say-it!
SAM Communicator®)
Spaced-Retrieval Training
PACE (Promoting Aphasics’ Communicative
Effectiveness)
Picture Naming Therapy
Constraint-Induced Aphasia Therapy
Interactive Metronome®
Communication Partner Training (e.g.,
Supported Conversation; Conversational
Coaching)
Sentactics®
Melodic Intonation Therapy
Sentence Production Program for Aphasia
(formerly HELPSS)
Treatment for Underlying Forms
Stimulation Approach (e.g., Workbook
exercises)
Response Elaboration Training
Computer Treatments (e.g., Parrot Software®;
Bungalow Software®; Lingraphica®)
Sentence Shaper®
Other (please specify)
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Estimate how much time passed
between when you learned and
when you first used each approach?
(Please use the answer key
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Appendix A: (Continued)
16. What factors have contributed to the time lag between exposure to and use of
treatment approaches? (Circle all that apply):
a) Did not have the appropriate client/caseload for the treatment
b) Wanted to learn more about the procedures of the treatment
c) Time required to gather materials necessary for the treatment
d) Materials for the treatment could not be purchased
e) Wanted to review the evidence base for the treatment
f) Wanted to ask colleagues’ opinions of the treatment
g) Other (please specify) _____________

SECTION VI: Implementation
17. What would facilitate your increased use of evidence-based practice related to your
treatment of patients with aphasia? (Please use the space below to provide your answer)

18. Describe situations which prompted you to seek and implement alternative treatment
approaches for patients with aphasia. (Please use the space below to provide your answer)
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Appendix B: Description of Survey Treatment Approaches
1. Augmentative and Alternative Communication (AAC)- Using high-tech or lowtech communication systems in an attempt to compensate for temporary or permanent
activity limitations and participation restrictions of persons with severe
communication disorders. AAC uses aided (e.g., real objects, pictures, line drawing,
orthography) or unaided (e.g., signs, gestures, facial expressions) symbols to convey
meaning for those with limited verbal abilities. Some commonly used AAC systems
for individuals with aphasia include communication books, speech generating devices
(SGD), remnant materials, pointing, gesturing, and pantomime (Beukelman &
Mirenda, 2005).
2. Communication Partner Training (CPT)- Involves training the communication
partner to identify behaviors that disrupt the communication and strategies for
eliminating those behaviors. The communication partner is trained to both
acknowledge and reveal the competence of the individual with language impairments.
Examples of CPT for individuals with aphasia include supported conversation and
conversational coaching (Murray & Clark, 2006)
3. Computer Treatments- High-tech systems that provide activities for a broad range
of linguistic and/or cognitive deficits. Examples of computer treatments for
individuals with aphasia include Parrot Software®, Bungalow Software®, and
Lingraphica®.
4. Constraint-Induced Aphasia Therapy (CIAT)- A high-intensity language treatment
consisting of both forced use of verbal language and massed practice. CIAT uses a
series of language games requiring verbal production shaped into successive
approximations of the target response. Nonverbal communication (e.g., pointing,
gestures, drawing) are not included in CIAT (Cherney et al., 2008).
5. Functional Communication Therapy (FCT)- Targets communication for daily life
activities such as communication necessary to perform job duties, participate in
desired leisure activities, and interact with family members (Murray & Clark, 2006).
6. Intensive Aphasia Therapy- Therapy is provided in a more concentrated way over a
short period of time (e.g., 10-30 hours of therapy weekly for a number of weeks).
Increased treatment time in intensive aphasia therapy allows for increased practice
with a broader range of communication skills.
7. Interactive Metronome®- An assessment and treatment tool which attempts to
improve the neurological processes of motor planning, sequencing, and processing.
IM uses a computer-generated reference tone and requires the user to match the
rhythmic beat with repetitive motor actions (www.interactivemetronome.com)
111

Appendix B: (Continued)
8. Melodic Intonation Therapy (MIT)- A stimulation treatment for clients with severe
nonfluent aphasia in which the user progresses from producing words and phrases in a
rhythmic manner (like singing) to producing these words with natural prosody
(Murray & Clark, 2006).
9. Picture .aming Therapy- Used for word-finding difficulties and training semantic
classification, PNT requires users to name a picture on a given stimulus item (e.g.,
photo card). Places little demand on the client’s working memory and allows for
control over the patient’s utterance to that of the picture (LaPoint, 1997).
10. Promoting Aphasics’ Communicative Effectiveness (PACE)- Using cards with
information printed on one side and placed face down on a table, the clinician and the
client take turns selecting a card and attempting to communicate the content of the
card to the other person. Allows the client to practice applying compensatory
strategies in a communication interaction (Murray & Clark, 2006).
11. Response Elaboration Training (RET)- A stimulation approach for clients with
nonfluent aphasia that involves reinforcement of client-initiated output, incidental
learning, and emphasis on utterance content. The clinician does not directly correct
the patient’s spontaneous utterances but provides indirect feedback via conversational
modeling (Murray & Clark, 2006).
12. Semantic Feature Analysis (SFA)- Attempts to activate the semantic network by
using a chart to help patients generate words that are semantically related to the target.
Clients are asked to name a picture as well as identify semantically related features
(e.g., use, location, action) (Murray & Clark, 2006).
13. Sentactics®- A computer-based treatment designed to improve sentence
comprehension and production in patients with Broca’s aphasia and agrammatism.
Attempts to train client with aphasia how to build a complex sentence from its simple
canonical form (www.bltek.com).
14. Sentence Production Program for Aphasia (SPPA)- Formerly known as the Helm
Elicited Program for Syntax Stimulation (HELPSS), SPPA trains the production of a
hierarchy of sentence constructions (i.e.., imperative intransitive, imperative
transitive, Wh- interrogative, declarative transitive, declarative intransitive,
comparative, passive, yes/no questions, direct and indirect object, embedded sentence,
and future). Trains sentence production at two levels: Level A, which elicits delayed
imitation, and Level B, which elicits spontaneous response (Murray & Clark, 2006).
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15. Sentence Shaper®- A software program which uses pictures and prompts to elicit
spoken productions. The user can record words or phrases and build them into
sentences by manipulating icons on a computer screen (www.sentenceshaper.com).
16. Spaced-Retrieval Training (SR)- Requires the user to practice the recall of
information over progressively longer periods of time. For example, the client may
be asked to recall a piece of information after a set amount of time. If recalled
accurately, the time is doubled. If recalled incorrectly or not recalled, the time is
reduced. Using this shaping procedure, the client can acquire and recall trained
information with little effort but generalization to untrained tasks is not expected
(Murray & Clark, 2006).
17. Stimulation Approach- Emphasizes the underlying stimulus factors that may
enhance/impede a client’s linguistic abilities by exposing the client to task hierarchies
that attempt to stimulate language functioning. Stimulation approach for aphasia
therapy often includes workbook exercises (Murray & Clark, 2006).
18. Treatment for Underlying Forms (TUFF)- Previously referred to as Linguistic
Specific Treatment, TUFF targets syntactically complex sentence types in an attempt
to remediate the client’s ability to process phrase movement. TUFF is based on
Noam Chomsky’s government binding theory and the idea that individuals with
agrammatism have difficulty processing grammatically complex sentences (Murray &
Clark, 2006).
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Appendix C: Recruitment E-Mail

Dear Colleague,
You are invited to participate in a survey study regarding approaches to aphasia therapy.
We hope that the results of this survey will help us to understand how clinicians use
evidence-based practice in their clinical decision making.
You may access the survey at:
http://www.c21te.usf.edu/survey/TakeSurvey.aspx?SurveyID=l4LJn62
The survey will take you approximately 10 minutes.
Thank you for your time and participation in this study. If you have any questions about
this study, please contact Erin Rowe at erowe@mail.usf.edu.

Erin Rowe
Graduate Clinician of Speech-Language Pathology
University of South Florida
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Appendix D: Invitation to Participate and Informed Consent

Informed Consent to Participate in Research
IRB Study # _______________

We are asking you to take part in a research study that is called:
Clinical Decision-Making in Aphasia Therapy: A Survey of Perceived Levels of Evidence
for Common Treatment Approaches

Purpose of the study
The purpose of this survey is to investigate clinical decision-making in aphasia treatment.
We hope that the results of this survey will help us to understand how clinicians use
evidence-based practice in their practice.
The survey will take you approximately 10 minutes. You are free to discontinue the
survey at any time. The survey is anonymous. Your responses to this survey will be
reported in grouped data.

Questions, concerns, or complaints
If you have any questions, concerns or complaints about this study, call Erin T. Rowe at
(941) 773-5300.

Consent to Take Part in this Research Study
Participation is optional. By initiating the survey, you are agreeing to participate in
research. Thank you for your participation.
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Appendix E: Survey Results Raw Data
Table 23. Raw Data for Number of Responses
Total Responses
Excluded (Do Not Treat Aphasia)
Excluded (Did Not Complete Survey)
Total Responses for Analysis

N = 117
N=8
N=5
. = 104

SECTION I: Demographics
Table 24. Raw Data for Survey Question 1
Do you currently see patients with aphasia as part of your caseload?
Response
Yes
No

.
109
8

%
93.16%
6.83%

Table 25. Raw Data for Survey Question 2
Approximately what percentage of your caseload consists of patients with aphasia?
Response
Less than 10%
About 25%
Between 33% - 66%
About 75%
More than 75%

.
17
26
28
9
24

%
16.34%
25.00%
26.92%
8.65%
23.07%

Table 26. Raw Data for Survey Question 3
Please indicate the age range in which your chronological age falls
Response
20-30 years
31-40 years
41-50 years
51-60 years
60+ years

.
11
14
37
34
8

%
10.57%
13.46%
35.57%
32.69%
7.69%
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Table 27. Raw Data for Survey Question 4
Please indicate your gender
Response
.
%
Male
8
7.69%
Female
96
92.30%
Table 28. Raw Data for Survey Question 5
Do you have a current state license in Speech-Language Pathology?
Response
Yes
No

.
97
7

%
93.26%
6.73%

Table 29. Raw data for Survey Question 6
Are you a member of any ASHA Special Interest Division?
SID
ASHA SID 1, Language Learning & Education
ASHA SID 2, Neurophysiology & Neurogenic Speech & Lang Dis
ASHA SID 3, Voice & Voice Dis
ASHA SID 4, Fluency & Fluency Dis
ASHA SID 5, Speech Science & Orofacial Dis
ASHA SID 6, Hearing & Hearing Dis: Research & Diagnostics
ASHA SID 7, Aural Rehabilitation & Its Instrumentation
ASHA SID 8, Hearing Conservation & Occupational Audiology
ASHA SID 9, Hearing & Hearing Dis in Childhood
ASHA SID 10, Issues in Higher Education
ASHA SID 11, Administration & Supervision
ASHA SID 12, Augmentative & Alternative Communication
ASHA SID 13, Swallowing & Swallowing Dis
ASHA SID 14, CSD in Culturally & Linguistically Diverse Pop
ASHA SID 15, Gerontology
ASHA SID 16, School-Based Issues
None
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.
2
80
10
2
1
0
0
0
0
6
12
9
29
4
13
2
16

%
1.92%
76.92%
9.61%
1.92%
0.96%
0%
0%
0%
0%
5.76%
11.53%
8.65%
27.88%
3.84%
12.50%
1.92%
15.38%

Appendix E: (Continued)
Table 30. Raw Data for Survey Question 7
Do you have any specialty credentials?
Response
Board Certified in Neurogenics, (ANCDS)
Board Recognized Specialist in Child Language
Board Recognized Specialist in Fluency & Fluency Dis
Board Recognized Specialist in Swallowing & Swallowing Dis
None
Other
Certified Brain Injury Specialist
LSVT Certification
Multiple Sclerosis Certified Specialist
Table 31. Raw Data for Survey Question 8
Highest degree earned
Response
Master’s degree
Doctoral degree
Clinical doctoral degree
Other

.
74
27
3
0

%
71.15%
25.95%
2.88%
0%

Table 32. Raw Data for Survey Question 9
How many years have you practiced as a Speech-Language Pathologist?
Response
Less than 2 years
2-5 years
6-10 years
11-15 years
16-20 years
20+ years

.
3
14
12
16
15
44

%
2.88%
13.46%
11.53%
15.38%
14.42%
42.30%
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.
9
0
1
1
89

%
8.65%
0%
0.96%
0.96%
85.57%

2
1
1

1.92%
0.96%
0.96%

Appendix E: (Continued)
Table 33. Raw Data for Survey Question 10
How many years have you had direct clinical experience with patients with aphasia?
Response
Less than 2 years
2-5 years
6-10 years
11-15 years
16-20 years
20+ years

.
3
15
16
15
14
41

%
2.88%
14.42%
15.38%
14.42%
13.46%
39.42%

Table 34. Raw Data for Survey Question 11
Please indicate the setting in which you currently see patients with aphasia
Response
Hospital
Skilled nursing facility
College / university clinic
Rehabilitation center
Private or group practice
Home health agency
Other

.
41
10
39
33
10
4
0

%
39.42%
9.61%
37.50%
31.73%
9.61%
3.84%
0%
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SECTION II: Aphasia Treatment Approaches
Table 35. Raw Data for Survey Question 12
Which of the following treatment approaches have you used/recommended in past year?
Treatment Approaches
Communication Partner Training (CPT)
Functional Communication Therapy (FCT)
Promoting Aphasics’ Communicative Effectiveness (PACE)
Augmentative and Alternative Communication (AAC)
Stimulation Approach
Melodic Intonation Therapy (MIT)
Semantic Feature Analysis (SFA)
Picture Naming Therapy
Computer Treatments
Intensive Aphasia Therapy
Response Elaboration Training (RET)
Sentence Production Program for Aphasia
Spaced-Retrieval Training (SRT)
Constraint-Induced Aphasia Therapy (CIAT)
Treatment for Underlying Forms (TUF)
Interactive Metronome® (IM)
Sentence Shaper® (SSR)
Sentactics®
Anagram, Copy, and Recall Therapy (ACRT/CART)
Oral Reading for Language in Aphasia (ORLA)
Amer-Ind
Scripts
Book Connection™
Cognitive-Linguistic Approaches
Cognitive Underpinnings
Cued Verb Treatment
English as a Second Language (ESL) Websites
Fluent Generative Naming
Gesture and Verbal Training (GVT)
Mapping
Multiple Oral Re-reading (MOR)
Phonological Components Analysis (PCA)
Picture Communication Boards
Problem-Solving Approach to Spelling
Repetition Priming
Semantic Phonetic Cueing Hierarchy
Simply Smart Aphasia Therapy (SSAT)
Treatment of Aphasic Perseveration (TAPS)
Visual Action Therapy (VAT)
Verb Network Strengthening Treatment (VNeST)
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.
74
72
70
65
59
55
53
45
40
40
33
31
31
24
12
5
5
2
7
4
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

%
71.15%
69.23%
67.30%
62.50%
56.73%
52.88%
50.96%
43.26%
38.46%
38.46%
31.73%
29.80%
29.80%
23.07%
11.53%
4.80%
4.80%
1.92%
6.73%
3.84%
1.92%
1.92%
0.96%
0.96%
0.96%
0.96%
0.96%
0.96%
0.96%
0.96%
0.96%
0.96%
0.96%
0.96%
0.96%
0.96%
0.96%
0.96%
0.96%
0.96%

Appendix E: (Continued)
SECTION III: Perceived Levels of Evidence
Table 36. Raw Data for Survey Question 13
How strong do you believe the evidence to be for each approach you selected?
Table 36-A. Communication Partner Training
Response
./36
No evidence
1
Minimal evidence
15
Moderate evidence
32
Strong evidence
15

%
1.58%
23.80%
50.79%
23.80%

Table 36-B. Functional Communication Therapy
Response
./63
%
No evidence
1
1.58%
Minimal evidence
25
39.68%
Moderate evidence
27
42.85%
Strong evidence
10
15.87%
Table 36-C. Promoting Aphasics’ Communicative Effectiveness
Response
./48
%
No evidence
0
0%
Minimal evidence
17
35.41%
Moderate evidence
25
52.08%
Strong evidence
6
12.50%
Table 36-D. Augmentative and Alternative Communication
Response
./53
%
No evidence
0
0%
Minimal evidence
24
45.28%
Moderate evidence
21
39.62%
Strong evidence
8
15.09%
Table 36-E. Stimulation Approach
Response
./41
No evidence
5
Minimal evidence
23
Moderate evidence
13
Strong evidence
0

%
12.19%
56.09%
31.70%
0%
121

Appendix E: (Continued)
Table 36-F. Melodic Intonation Therapy
Response
./44
No evidence
0
Minimal evidence
21
Moderate evidence
18
Strong evidence
5

%
0%
47.72%
40.90%
11.36%

Table 36-G. Semantic Feature Analysis
Response
./46
No evidence
0
Minimal evidence
8
Moderate evidence
34
Strong evidence
4

%
0%
17.39%
73.91%
8.69%

Table 36-H. Picture Naming Therapy
Response
./36
No evidence
0
Minimal evidence
18
Moderate evidence
15
Strong evidence
3

%
0%
50.00%
41.66%
8.33%

Table 36-I. Computer Treatments
Response
No evidence
Minimal evidence
Moderate evidence
Strong evidence

./30
2
13
13
2

%
6.66%
43.33%
43.33%
6.66%

Table 36-J. Intensive Aphasia Therapy
Response
./54
No evidence
0
Minimal evidence
16
Moderate evidence
23
Strong evidence
15

%
0%
29.62%
42.59%
27.77%
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Table 36-K. Response Elaboration Training
Response
./25
No evidence
1
Minimal evidence
10
Moderate evidence
9
Strong evidence
5

%
4.00%
40.00%
36.00%
20.00%

Table 36-L. Sentence Production Program for Aphasia
Response
./26
%
No evidence
3
11.53%
Minimal evidence
13
50.00%
Moderate evidence
8
30.76%
Strong evidence
2
7.69%
Table 36-M. Spaced-Retrieval Training
Response
./26
No evidence
0
Minimal evidence
9
Moderate evidence
15
Strong evidence
2

%
0%
34.61%
57.69%
7.69%

Table 36-N. Constraint-Induced Aphasia Therapy
Response
./16
%
No evidence
0
0%
Minimal evidence
4
25.00%
Moderate evidence
8
50.00%
Strong evidence
4
25.00%
Table 36-O. Treatment for Underlying Forms
Response
./11
No evidence
0
Minimal evidence
Moderate evidence
Strong evidence

1
9
1

%
0%
9.09%
81.81%
9.09%
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Table 36-P. Interactive Metronome
Response
./2
No evidence
0
Minimal evidence
0
Moderate evidence
0
Strong evidence
2

%
0%
0%
0%
100%

Table 36-Q. Sentence Shaper
Response
No evidence
Minimal evidence
Moderate evidence
Strong evidence

./4
0
2
2
0

%
0%
50.00%
50.00%
0%

Table 36-R. Sentactics
Response
No evidence
Minimal evidence
Moderate evidence
Strong evidence

./2
1
0
1
0

%
50%
0%
50%
0%

Table 36-S. Anagram, Copy, and Recall Therapy
Response
./6
%
No evidence
0
0%
Minimal evidence
2
33.33%
Moderate evidence
3
50.00%
Strong evidence
1
16.66%
Table 36-T. Oral Reading for Language in Aphasia
Response
./4
%
No evidence
0
0%
Minimal evidence
2
50.00%
Moderate evidence
1
25.00%
Strong evidence
1
25.00%
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Table 36-U. Amer-Ind
Response
No evidence
Minimal evidence
Moderate evidence
Strong evidence

./1
0
1
0
0

%
0%
100.00%
0%
0%

Table 36-V. Scripts
Response
No evidence
Minimal evidence
Moderate evidence
Strong evidence

./2
0
0
2
0

%
0%
0%
100.00%
0%

Table 36-W. Treatment Approaches Perceived as Having “Minimal” Evidence
Treatment Approaches Rated
% of Respondents Rating
“Minimal Evidence”
“Minimal Evidence”
Stimulation Approach
56.09%
Picture Naming Therapy
50.00%
Sentence Production Program for Aphasia
50.00%
Other
Oral Reading for Language in Aphasia (ORLA)
50.00%
Amer-Ind
100.00%
Table 36-X. Treatment Approaches in Perceived as Having “Moderate” Evidence
Treatment Approaches Rated
% of Respondents Rating
“Moderate Evidence”
“Moderate Evidence”
Treatment for Underlying Forms (TUF)
81.81%
Semantic Feature Analysis (SFA)
73.91%
Spaced-Retrieval Training (SRT)
57.69%
Promoting Aphasics’ Communicative Effectiveness
52.08%
(PACE)
Communication Partner Training (CPT)
50.79%
Constraint-Induced Aphasia Therapy (CIAT)
50.00%
Other
Scripts
100.00%
Anagram, Copy, & Recall Therapy (ACRT/CART)
50.00%
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SECTION IV: Sources of Information
Table 37. Raw Data for Survey Question 14
What has been your primary means of attaining information regarding each approach?
Table 37-A. Communication Partner Training
Response
./62
Grad School
6
Conference
17
Advertisement
0
Magazine
2
Journal
23
Colleague
11
Other
3

%
9.67%
27.41%
0%
3.22%
37.09%
17.74%
4.83%

Table 37-B. Functional Communication Therapy
Response
./60
Grad School
16
Conference
14
Advertisement
0
Magazine
2
Journal
18
Colleague
6
Other
4

%
26.66%
23.33%
0%
3.33%
30.00%
10.00%
6.66%

Table 37-C. Promoting Aphasics’ Communicative Effectiveness
Response
./46
%
Grad School
22
47.82%
Conference
6
13.04%
Advertisement
0
0%
Magazine
1
2.17%
Journal
11
23.91%
Colleague
5
10.86%
Other
1
2.17%
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Table 37-D. Augmentative and Alternative Communication
Response
./53
%
Grad School
17
32.07%
Conference
16
30.18%
Advertisement
0
0%
Magazine
0
0%
Journal
7
13.20%
Colleague
8
15.09%
Other
5
9.43%
Table 37-E. Stimulation Approach
Response
./44
Grad School
31
Conference
1
Advertisement
0
Magazine
0
Journal
4
Colleague
5
Other
3

%
70.45%
2.27%
0%
0%
9.09%
11.36%
6.81%

Table 37-F. Melodic Intonation Therapy
Response
./45
Grad School
24
Conference
2
Advertisement
0
Magazine
0
Journal
15
Colleague
2
Other
2

%
53.33%
4.44%
0%
0%
33.33%
4.44%
4.44%

Table 37-G. Semantic Feature Analysis
Response
./45
Grad School
9
Conference
3
Advertisement
0
Magazine
2
Journal
25
Colleague
4
Other
2

%
20.00%
6.66%
0%
4.44%
55.55%
8.88%
4.44%
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Table 37-H. Picture Naming Therapy
Response
./32
Grad School
21
Conference
3
Advertisement
0
Magazine
0
Journal
5
Colleague
3
Other
0

%
65.62%
9.37%
0%
0%
15.62%
9.37%
0%

Table 37-I. Computer Treatments
Response
Grad School
Conference
Advertisement
Magazine
Journal
Colleague
Other

./32
1
7
3
1
4
7
9

%
3.12%
21.87%
9.37%
3.12%
12.50%
21.87%
28.12%

Table 37-J. Intensive Aphasia Therapy
Response
./32
Grad School
9
Conference
2
Advertisement
1
Magazine
0
Journal
12
Colleague
6
Other
2

%
28.12%
6.25%
3.12%
0%
37.50%
18.75%
6.25%

Table 37-K. Response Elaboration Training
Response
./25
Grad School
5
Conference
2
Advertisement
0
Magazine
0
Journal
12
Colleague
5
Other
1

%
20.00%
8.00%
0%
0%
48.00%
20.00%
4.00%
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Table 37-L. Sentence Production Program for Aphasia
Response
./24
%
Grad School
8
33.33%
Conference
1
4.16%
Advertisement
0
0%
Magazine
0
0%
Journal
8
33.33%
Colleague
4
16.66%
Other
3
12.50%
Table 37-M. Spaced-Retrieval Training
Response
./25
Grad School
3
Conference
6
Advertisement
0
Magazine
0
Journal
12
Colleague
3
Other
1

%
12.00%
24.00%
0%
0%
48.00%
12.00%
4.00%

Table 37-N. Constraint-Induced Aphasia Therapy
Response
./16
Grad School
2
Conference
5
Advertisement
0
Magazine
1
Journal
8
Colleague
0
Other
0

%
12.50%
31.25%
0%
6.25%
50.00%
0%
0%

Table 37-O. Treatment for Underlying Forms
Response
./12
Grad School
0
Conference
1
Advertisement
0
Magazine
0
Journal
10
Colleague
0
Other
1

%
0%
8.33%
0%
0%
83.33%
0%
8.33%
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Appendix E: (Continued)
Table 37-P. Interactive Metronome
Response
./2
Grad School
0
Conference
1
Advertisement
0
Magazine
0
Journal
0
Colleague
1
Other
0

%
0%
50.00%
0%
0%
0%
50.00%
0%

Table 37-Q. Sentence Shaper
Response
Grad School
Conference
Advertisement
Magazine
Journal
Colleague
Other

./4
0
0
0
0
2
1
1

%
0%
0%
0%
0%
50.00%
25.00%
25.00%

Table 37-R. Sentactics
Response
Grad School
Conference
Advertisement
Magazine
Journal
Colleague
Other

./1
0
0
0
0
0
1
0

%
0%
0%
0%
0%
0%
100%
0%

Table 37-S. Anagram, Copy, and Recall Therapy
Response
./4
%
Grad School
0
0%
Conference
0
0%
Advertisement
0
0%
Magazine
0
0%
Journal
2
50.00%
Colleague
1
25.00%
Other
1
25.00%
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Appendix E: (Continued)
Table 37-T. Oral Reading for Language in Aphasia
Response
./4
%
Grad School
0
0%
Conference
1
25.00%
Advertisement
0
0%
Magazine
0
0%
Journal
1
25.00%
Colleague
2
50.00%
Other
0
0%
Table 37-U. Amer-Ind
Response
Grad School
Conference
Advertisement
Magazine
Journal
Colleague
Other

./0
0
0
0
0
0
0
0

%
0%
0%
0%
0%
0%
0%
0%

Table 37-V. Scripts
Response
Grad School
Conference
Advertisement
Magazine
Journal
Colleague
Other

./2
0
0
0
0
1
1
0

%
0%
0%
0%
0%
50.00%
50.00%
0%

Table 37-W. Treatment Approaches Learned in Graduate School
Treatment Approaches Reported to be
% of Respondents Selecting
Learned In “Graduate School”
“Graduate School” As Primary
Source of Information
Stimulation Approach
70.45%
Picture Naming Therapy
65.62%
Melodic Intonation Therapy (MIT)
53.33%
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Appendix E: (Continued)
Table 37-X. Treatment Approaches Learned in Professional Journals
Treatment Approaches Reported to be
% of Respondents Selecting
Learned In “Professional Journal”
“Professional Journal” As Primary
Source of Information
Treatment For Underlying Forms (TUF)
83.33%
Semantic Feature Analysis (SFA)
55.55%
Constraint-Induced Aphasia Therapy (CIAT)
50.00%
Sentence Shaper
50.00%
Other
50.00%
Anagram, Copy, and Recall Therapy
50.00%
(ACRT/CART)
Scripts
Table 37-Y. Overall Frequency of Sources Reported
Source of Information
.
Professional Journal
180
Graduate School
174
Conference
88
Colleague
76
Other
39
Magazine
9
Advertisement
4

% of Respondents
31.57%
30.52%
15.43%
13.33%
6.84%
1.57%
0.70%

SECTION V: Exposure Prior to Use
Table 38. Raw Data for Survey Question 15
Looking back, how much time would you estimate passed between when you first
learned of each approach and when you first used it in practice?
Table 38-A. Communication Partner Training
Response
./57
0-3 Months
36
4-6 Months
10
6-9 Months
4
9-12 Months
4
>12 Months
3
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%
63.15%
17.54%
7.01%
7.01%
5.26%

Appendix E: (Continued)
Table 38-B. Functional Communication Therapy
Response
./54
%
0-3 Months
40
74.07%
4-6 Months
2
3.70%
6-9 Months
2
3.70%
9-12 Months
4
7.40%
>12 Months
6
11.11%
Table 38-C. Promoting Aphasics’ Communicative Effectiveness
Response
./40
%
0-3 Months
24
60.00%
4-6 Months
8
20.00%
6-9 Months
2
5.00%
9-12 Months
2
5.00%
>12 Months
4
10.00%
Table 38-D. Augmentative and Alternative Communication
Response
./49
%
0-3 Months
24
48.97%
4-6 Months
4
8.16%
6-9 Months
7
14.28%
9-12 Months
5
10.20%
>12 Months
9
18.36%
Table 38-E. Stimulation Approach
Response
./40
0-3 Months
32
4-6 Months
3
6-9 Months
2
9-12 Months
1
>12 Months
2

%
80.00%
7.50%
5.00%
2.50%
5.00%

Table 38-F. Melodic Intonation Therapy
Response
./38
0-3 Months
15
4-6 Months
5
6-9 Months
6
9-12 Months
2
>12 Months
10

%
39.47%
13.15%
15.78%
5.26%
26.31%
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Appendix E: (Continued)
Table 38-G. Semantic Feature Analysis
Response
./38
0-3 Months
23
4-6 Months
7
6-9 Months
4
9-12 Months
2
>12 Months
2

%
60.52%
18.42%
10.52%
5.26%
5.26%

Table 38-H. Picture Naming Therapy
Response
./26
0-3 Months
22
4-6 Months
1
6-9 Months
0
9-12 Months
1
>12 Months
2

%
84.61%
3.84%
0%
3.84%
7.69%

Table 38-I. Computer Treatments
Response
0-3 Months
4-6 Months
6-9 Months
9-12 Months
>12 Months

./28
17
5
2
0
4

%
60.71%
17.85%
7.14%
0%
14.28%

Table 38-J. Intensive Aphasia Therapy
Response
./27
0-3 Months
13
4-6 Months
5
6-9 Months
0
9-12 Months
1
>12 Months
8

%
48.14%
18.51%
0%
3.70%
29.62%

Table 38-K. Response Elaboration Training
Response
./24
0-3 Months
12
4-6 Months
5
6-9 Months
2
9-12 Months
2
>12 Months
3

%
50.00%
20.83%
8.33%
8.33%
12.50%
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Appendix E: (Continued)
Table 38-L. Sentence Production Program for Aphasia
Response
./21
%
0-3 Months
12
57.14%
4-6 Months
1
4.76%
6-9 Months
2
9.52%
9-12 Months
2
9.52%
>12 Months
4
19.04%
Table 38-M. Spaced-Retrieval Training
Response
./22
0-3 Months
13
4-6 Months
4
6-9 Months
0
9-12 Months
3
>12 Months
2

%
59.09%
18.18%
0%
13.63%
9.09%

Table 38-N. Constraint-Induced Aphasia Therapy
Response
./13
0-3 Months
8
4-6 Months
2
6-9 Months
1
9-12 Months
1
>12 Months
1

%
61.53%
15.38%
7.69%
7.69%
7.69%

Table 38-O. Treatment for Underlying Forms
Response
./10
0-3 Months
3
4-6 Months
2
6-9 Months
1
9-12 Months
2
>12 Months
2

%
30.00%
20.00%
10.00%
20.00%
20.00%

Table 38-P. Interactive Metronome
Response
./2
0-3 Months
0
4-6 Months
1
6-9 Months
1
9-12 Months
0
>12 Months
0

%
0%
50.00%
50.00%
0%
0%
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Appendix E: (Continued)
Table 38-Q. Sentence Shaper
Response
0-3 Months
4-6 Months
6-9 Months
9-12 Months
>12 Months

./3
0
1
0
1
1

%
0%
33.33%
0%
33.33%
33.33%

Table 38-R. Sentactics
Response
0-3 Months
4-6 Months
6-9 Months
9-12 Months
>12 Months

./2
1
0
0
0
1

%
50.00%
0%
0%
0%
50.00%

Table 38-S. Anagram, Copy, and Recall Therapy
Response
./3
0-3 Months
3
4-6 Months
0
6-9 Months
0
9-12 Months
0
>12 Months
0

%
100%
0%
0%
0%
0%

Table 38-T. Oral Reading for Language in Aphasia
Response
./3
0-3 Months
3
4-6 Months
0
6-9 Months
0
9-12 Months
0
>12 Months
0

%
100%
0%
0%
0%
0%

Table 38-U. Amer-Ind
Response
0-3 Months
4-6 Months
6-9 Months
9-12 Months
>12 Months

./0
0
0
0
0
0

%
0%
0%
0%
0%
0%
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Appendix E: (Continued)
Table 38-V. Scripts
Response
0-3 Months
4-6 Months
6-9 Months
9-12 Months
>12 Months

./1
1
0
0
0
0

%
100%
0%
0%
0%
0%

Table 38-W. Treatment Approaches Implemented Within Three Months of Exposure
Treatment Approaches Reported to be
% of Respondents Selecting
Implemented Within “0-3 Months” of Learning
“0-3 Months”
Picture Naming Therapy
84.61%
Stimulation Approach
80.00%
Functional Communication Therapy (FCT)
74.07%
Communication Partner Training (CPT)
63.15%
Constraint-Induced Aphasia Therapy (CIAT)
61.53%
Computer Treatments
60.71%
Semantic Feature Analysis (SFA)
60.52%
Promoting Aphasics’ Communicative Effectiveness
60.00%
(PACE)
Spaced-Retrieval Training (SRT)
59.09%
Sentence Production Program for Aphasia
57.14%
Response Elaboration Training (RET)
50.00%
Sentactics
50.00%
Table 39. Raw Data for Survey Question 16
What factors have contributed to the time lag between exposure to and use of treatment
approaches?
Response
n
%
Did not have the appropriate client/caseload for the
62
59.61%
treatment
Wanted to learn more about the procedures of the treatment
36
34.61%
Wanted to review the evidence base for the treatment
28
26.92%
Time required to gather materials necessary for the
27
25.96%
treatment
Wanted to ask colleagues’ opinions of the treatment
21
20.19%
Materials for the treatment could not be purchased
14
13.46%
Other
0
0%
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Appendix E: (Continued)
SECTION VI: Implementation
Table 40. Raw Data for Survey Question 17
What would facilitate your increased use of evidence-based practice related to your
treatment of patients with aphasia?
Trend Category
Increased ease of access to
information
Need for practice-based information
Allocation of financial resources
Lack of time
Non-codable/Irrelevant

Comments Identified
36

% of Comments
45.00%

23
8
7
6

28.75%
10.00%
8.75%
7.50%

Table 41. Raw Data for Survey Question 18
Describe situations which prompted you to seek and implement alternative treatment
approaches for patients with aphasia.
Trend Category
Lack of treatment success
Client need
Challenging diagnoses
Interest in a new treatment approach
Clinician expertise
Non-codable/Irrelevant

Comments Identified
28
19
13
5
5
6
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% of Comments
36.8%
25.0%
17.1%
6.6%
6.6%
7.9%

